Next Article in Journal
Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
Previous Article in Journal
Role of Lipopolysaccharide in Protecting OmpT from Autoproteolysis during In Vitro Refolding
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions

by
Mohammad A. I. Al-Hatamleh
1,
Jennifer C. Boer
2,
Kirsty L. Wilson
2,
Magdalena Plebanski
2,
Rohimah Mohamud
1,3 and
Mohd Zulkifli Mustafa
3,4,*
1
Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
2
Translational Immunology and Nanotechnology Unit, School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia
3
Hospital Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
4
Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
*
Author to whom correspondence should be addressed.
Biomolecules 2020, 10(6), 923; https://doi.org/10.3390/biom10060923
Submission received: 9 May 2020 / Revised: 10 June 2020 / Accepted: 15 June 2020 / Published: 18 June 2020
(This article belongs to the Section Natural and Bio-derived Molecules)

Abstract

:
Stingless bees are a type of honey producers that commonly live in tropical countries. Their use for honey is being abandoned due to its limited production. However, the recent improvements in stingless bee honey production, particularly in South East Asia, have brought stingless bee products back into the picture. Although there are many stingless bee species that produce a wide spread of products, known since old eras in traditional medicine, the modern medical community is still missing more investigational studies on stingless bee products. Whereas comprehensive studies in the current era attest to the biological and medicinal properties of honeybee (Apis mellifera) products, the properties of stingless bee products are less known. This review highlights for the first time the medicinal benefits of stingless bee products (honey, propolis, pollen and cerumen), recent investigations and promising future directions. This review emphasizes the potential antioxidant properties of these products that in turn play a vital role in preventing and treating diseases associated with oxidative stress, microbial infections and inflammatory disorders. Summarizing all these data and insights in one manuscript may increase the commercial value of stingless bee products as a food ingredient. This review will also highlight the utility of stingless bee products in the context of medicinal and therapeutic properties, some of which are yet to be discovered.

1. Introduction

Stingless bees (Meliponines) belong to the genus Apidae, which is a family of social bees from the superfamily Apoidea. Stingless bees are the highest developed species of bees that have been identified in 80 million years old parts of amber [1]. Reports of ancient populations using honey both for nutritional and medicinal properties can be traced back to nearly 5500 years ago [2]. Hand collecting honey bees was an important traditional practice in many ancient populations as it was the only way to get honey and it still persists among some people in forest areas [1]. To date there are more than 500 known stingless bee species, of which approximately 40 species have good potential as honey producers [3,4]. These species are distributed in the tropical and subtropical regions as follows: approximately 391 species in the Neotropical region of South America, 60 in the Indo-Malayan region of Asia, 50 in the Paleotropical region of Africa and 10 in the Australasia region of Australia [5]. Constructing nests in hollow tree trunks or roots, soil cavities or empty animal narrow nests is typical for many stingless bee honey (SBH) producer species [1]. As pollinators, stingless bees play an important role in the forest ecosystem by strongly influencing plant community, diversity and evolution.
The most common species producing SBH are classified under two main genera, Melipona and Trigona [6]. While stingless bees are one of the most common types of honey producers, the distribution of SBH is lower compared to the more common honey produced by Apis mellifera bees (European/Western bees or honeybees) [7], which has been associated with the limited data about SBH production and its properties. Interestingly, SBH is less used as a nutritional and medicinal product [8], despite its higher nutritional and medicinal properties compared to the commonly used honeybee products (European/Western honey) [9,10,11,12]. It is believed that stingless bee products are superior promising sources of biologically active compounds over honeybees, and this can be attributed to the rich vegetation in the tropical and subtropical regions where stingless bees are found [7]. In addition, stingless bees have some principal characteristics that make them unique compared to honeybees, for example they are less vulnerable to disease (Figure 1). Recent evidence indicates that SBH has potential therapeutic benefits in several contexts, including wound healing, diabetes mellitus, eye diseases, hypertension, fertility defects, cancer, microbial infection and dysregulated lipid profiles [13]. Therefore, promoting the research on SBH would help improve the knowledge on its putative medicinal properties and ensure the conservation of SBH trade.
It is important to note that stingless bee products are not restricted to honey, but can involve several products including propolis, beebread, cerumen and bee pollen (Figure 2). Although these are not as common as honey, studies have reported several medicinal properties in those products too [14,15,16]. Based on a comparison between the studies on stingless bees and honeybees, a significant gap in research on stingless bee products has been identified compared to the common honeybee products that are well-studied (Figure 3). Interestingly, in 2019, approximately double the number of studies on stingless bees were reported (Figure 3). To improve the awareness on the stingless bee, its products, properties, benefits and future opportunities, this manuscript provides a comprehensive review and recent updates on the medicinal properties of stingless bee products. We also highlight the importance of increasing research investments into stingless bee products for future medical research, as well as to motivate their production and nutritional usage.

2. Harvesting and Characterization of Stingless Bee Products

The percentages of stingless bee products in the beehive are still unknown; it supposed to be varied according to the species. Generally, propolis is main content of stingless bee hive, regardless the species, as the hive is constructed with it [17]. A study on nine Trigona species reported that the hive products of those species were 63.7% propolis, 20.9% beebread and 15.4% honey [18]. Furthermore, the proportion of use for each stingless bee product in the medicinal/commercial industry is also unknown.
Stingless bees produce their honey and store it in small resin pots in the hive. In traditional practices, honey pots were commonly squeezed to obtain the honey [19]. This method led to several disadvantages such as damaging the pot and reducing the productivity of the bees. In fact, honey obtained by squeezing the pot produced SBH contaminated with bee bread, which promoted souring of the honey and produced inconsistent honey products [20]. To overcome this, current practices in stingless beekeeping promote the hiving method with a monolayer honey pot induction system that utilizes suction pumps to aspirate the honey pot by pot without damaging the pots [21]. This method produces absolute and hygienic honey as well as supporting sustainable stingless beekeeping. However, so far there are no standard methods for harvesting other stingless bee products. Beekeepers harvest each of these products by removing it directly from the hive. Menezes et al. have suggested a good method for harvesting unfermented pollen from stingless bees by moving a colony of stingless bees to a another location and stimulate the foragers to accept a new hive, build new pots and leaving the old hive empty [22]. After a week they easily and precisely harvested the pollen from the pots of empty hive.
Despite an improvement in harvesting practices and post-harvest management of SBH, stingless bee products display variability in chemical composition associated with botanical and geographical origin, bee species and climate. Therefore, a standard characterization worldwide for stingless bee products is not available. However, Malaysia has specifically developed the first SBH standard referred to as Malaysian standard (MS) 2683:2017 [23]. It is used in local regulations according to several parameters including moisture content (<35.0%), sucrose (<7.5 g/100 g), sum of fructose and glucose (<85.0 g/100 g), maltose (<9.5 g/100 g), ash (<1.0 g/100 g), hydroxymethylfurfural (<30.0 mg/kg), pH (2.5–3.8) and identifying the plant phenolic content [23]. Additionally, this standard also set the microbial contaminant with total plate count limits at 1 × 103 CFU/mL, whereas yeast, mold and coliforms must be less than 1 × 101 CFU/mL [23].

3. Stingless Bee Honey

Given that studies on the medicinal properties of SBH are still limited with the majority being focused on common health problems (such as inflammation, cancer and microbial infection), this review outlines the studies that have utilized SBH and highlights the reported beneficial properties of SBH (Table 1). The health benefits of SBH can be broadly classified as having antioxidant, anti-inflammatory, anti-obesity, anticancer and antimicrobial properties.

3.1. Antioxidant Activity of SBH

The antioxidant activity assay for any product is based on the capability of the compounds to inhibit oxidation, thus reducing production of free radicals that result in a chain reaction causing harmful cellular alterations [50]. Studies have reported that antioxidant activity is significantly correlated with several healing properties, such as anti-inflammatory, antimicrobial, anticancer and anti-obesity activities [30,32,38,51]. This is not surprising given the role of antioxidants in oxidative stress/damage is well-known and is implicated in a wide range of diseases (Figure 4). Furthermore, the role of antioxidants is not limited to scavenging free radicals; it also have good potentials to modulate signal transduction pathways that affected by free radicals during oxidative stress and are responsible to cellular responses (e.g., inflammation, survival, proliferation and death) in various diseases [52,53]. Reinisalo et al. have shown that both the nuclear factor-erythroid-2-related factor-2 (Nrf2) pathway and intracellular cyclic AMP (cAMP) second messenger system can be modulated by antioxidant compounds [54]. Activation of Nrf2 results in activation of some Nrf2 target gene candidates (e.g., Nrf2, SLC48A1, SLC7A11, p62, HO-1 and Bcl-2 genes) that control antioxidant defense and autophagy. While inhibition of phosphodiesterases (PDE) promotes intracellular cAMP levels, and therefore, activation of cAMP response element-binding protein (CREB) target genes and AMP-activated protein kinase (AMPK) pathway, which is the key regulator of autophagy and also involves in regulation of Nrf2 pathway [54].
Generally, it has been suggested that the number of hydroxyl groups in the aromatic rings of antioxidants is relatively associated with their effectiveness [57]. Higher antioxidant activities have been correlated to honeys with darker colors, as the dark color derives from different pigment compounds such as flavonoids, carotenoids and phenolic compounds, the compounds that provide antioxidant properties to honey [58]. Indeed, studies from Selvaraju and others have suggested that SBH contains high concentrations of total pollen, flavonoid and phenolic contents and color intensity [30,31].
Many studies have explored the total phenolic content (TPC) and the total flavonoid content (TFC), calculated in mg gallic acid equivalent (GAE)/g sample, and the characterization of the phenolic compounds have been performed by different methods, especially the high performance liquid chromatography-mass spectrometric (LC-MS) [59,60]. While the most common assays to detect the antioxidant activity were DPPH (2,2-diphenyl-1-picryl-hydrazyl-hydrate)-free radical scavenging activity, ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical cation scavenging activity and ferric reducing antioxidant power (FRAP) [16,28,31,59,60]. These three assays considered as relatively inexpensiveness spectrophotometric-based tests based on color quenching or gaining of synthetic organic radicals. The colors of DPPH (purple) and ABTS (blue–green) are reducible upon exposure to antioxidants, and this decrease is negatively correlated with the measured wavelength, which, thus, refers to the antioxidant capacity [61]. While the FARP assay works in reverse; the increase in color density (decrease in wavelength) refers to higher antioxidant capacity. In this assay, ferric-tripyridyl triazine (Fe3+ TPTZ) is colorless and it is convertible to be ferrous (Fe2+) with blue color upon electron donation from antioxidants [62]. Among the several classes of phenolic compounds, a total of 16 phenolic acids (Figure 5), 19 flavonoids (Figure 6) and other five phenolic compounds (Figure 7) have been reported in SBHs at different concentrations [31,59,60,63]. The major compounds that commonly been reported are gallic acid, salicylic acid, p-coumaric acid, kaempferol, naringin, luteolin, catechin, apigenin and taxifolin [31,59,60,63]. The concentration of phenolic compounds differed based on the species of stingless bees and the vegetation at the sites of SBH collection [60]. These findings were supported by a study has compiled compositional data from 152 stingless bee honeys during 42 years (2006–1964) [21].
The antioxidant effects of SBH have been shown in a study conducted on a diabetic rat model. Animals underwent treatment with SBH, which caused increased levels of superoxide dismutase and glutathione (antioxidant enzymes), whereas protein carbonyl and malondialdehyde (biomarkers of oxidative stress) levels decreased in their sperms and testis, thus, improving the quality of their sperm [39]. Another study reported that the significant increase in cell viability of lymphoblastoid cell line (LCL) might be modulated by the antioxidant properties of SBH [28]. LCL viability was significantly higher during 24 h of treatment with SBH, while a decline in viability was reported after that with higher concentrations of SBH. These findings are in line with results of a comparable wound healing study on human fibroblast cells using freeze-dried SBH [36]. All together, these studies indicate that in a concentration-dependent manner, different antioxidant compounds of SBH could play a vital role in the increment or decline of cell viability by modulating oxidative stress and cytotoxicity.

3.2. Anti-Inflammatory Activity of SBH

In broad terms, inflammation is a complex immunological defense mechanism rising either against harmful stimuli or as a result of an excessive response to a normal stimulus perceived as harmful [64]. Either way, oxidative stress plays an important role in this context as it can lead to inflammation and contribute to worsening of the condition [65]. Because of their strong antioxidant and therefore immunomodulatory activity, phenolic compounds have been proposed as compounds to use for anti-inflammatory therapy [66]. Therefore, as oxidation plays an important role in the inflammation status, anti-inflammatory products like honey, rich with antioxidant substances, have been widely used to improve inflammation and associated disorders [67]. Figure 8 briefly illustrates potential anti-inflammatory mechanisms of action for SBH based on its antioxidant activity.
This antioxidant activity would also inhibit essential enzymes responsible to the endogenous production of reactive oxygen species (ROS) during the metabolism of arachidonic acid, such as nitric oxide synthases (NOSs), cytochrome P450 (CP450), NADPH oxidase (NOX), xanthine oxidase (XO) lipoxygenase (LO), cyclooxygenases (COXs) and myeloperoxidase (MP) [68,69]. The expression of these enzymes is stimulated in the inflammatory conditions, and therefore, inhibition of these enzymes will stop ROS production that leads to reduce oxidative stress and then an anti-inflammatory effect [68,69]. Since mediators of inflammation play crucial roles in various diseases (e.g., cancer and obesity) [70,71], SBH could also rely on these mechanisms of action in modulating the inflammatory-associated diseases.
Borsato et al. reported that SBH extract has anti-inflammatory activity to reduce ear edema, probably due to a synergistic effect of its phenolic compounds (such as kaempferol and caffeic acid) [44]. It also provided a reduction in the myeloperoxidase activity along with lower leukocyte infiltration and reduced ROS production [44]. Another study on rats with selenite-induced cataract showed that there was a delay in opacification on the eye receiving treatment with SBH directly applied as a drop. [49]. Further investigation on SBH showed that the compound has even more systemic effects when administered orally to lipopolysaccharide (LPS)-induced chronic subclinical system inflammation (CSSI) rats [32]. In this context treatment with SBH significantly modulated serum inflammatory markers, such as tumor necrosis factor-alpha (TNF)-α, interleukin (IL)-1β, IL-6, IL-8, IL-10 and monocyte chemoattractant protein-1 (MCP-1), while it enhanced antioxidants like malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) [25,32]. However, Syam et al. observed that SBH induces mRNA expression of IL-6 in mice Balb/c strain infected with Salmonella typhi [42]. Altogether, these studies provided valuable insights into the potent anti-inflammatory activity of SBH, in part via its modulatory effects on reducing leukocytes infiltration and cytokines section.

3.3. Anti-Obesity Activity of SBH

Obesity and overweight is a worldwide health concern associated with poorer quality of life, and it is one of the leading causes of many serious diseases, including high blood pressure, diabetes and cardiovascular disease [72]. It has been reported that the high oxidative stress associated with obesity is a leading cause of inflammation [71]. Products containing high antioxidant substances showed significant anti-obesity activity [73].
In a study conducted on obese rats treated with SBH, a significant reduction was observed in body mass index (BMI), percentage of body weight gain, adiposity index, relative organ weight (ROW), liver enzymes, triglycerides and low-density lipoprotein (LDL), while the level of high-density lipoprotein (HDL) was significantly increased [34]. SBH treatment showed a reduced number of adipocyte cells, while the hepatocytes found in the liver were less prone to rupturing when treated with SBH, suggesting that SBH improved the indicators associated with obesity reduction and reduced the health risks related to obesity [34]. Another study on diabetic rats showed that SBH kept fasting blood glucose, total cholesterols, triglyceride and LDL cholesterol at low levels, whereas serum insulin and HDL cholesterol levels were increased [38]. In addition, some inflammatory markers, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), inhibitor of nuclear factor kappa-B kinase subunit beta (IKK-β), tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) and apoptosis marker caspase-9 showed a steady decrease following treatment with SBH, while anti-oxidative enzyme catalase was increased [38]. Together, these studies have shown that not only the antidiabetic properties of SBH as a protection agent against pancreas dysfunction, it also highlighted the potential anti-obesity activity of SBH, by maintaining the lipid profile in homeostasis and could even affect the morphological structures in the liver [34,38].

3.4. Anticancer Activity of SBH

It is well-known that inflammatory cells control the cancer microenvironment, while inflammation plays a crucial role in cancer progression [74,75]. It is also reported in a mechanistic review that the mechanisms for anticancer activity of honey are antioxidant, anti-inflammatory, apoptotic, immunomodulatory, TNF inhibiting, antiproliferative and provide estrogenic effects [76]. However, this study was not specific to SBH, and although there are some studies that have reported the anticancer activity of SBH, though the mechanisms of its activity are still not completely clear.
In 2016, Saiful Yazan et al. used SBH to treat rats with colorectal cancer and showed that SBH has chemo-preventative properties; this finding demonstrated by the total number of aberrant crypts and aberrant crypt foci, and crypt multiplicity all were significantly decreased [41]. Besides, their full blood count (FBC), kidney function tests (KFT) and liver function tests (LFT) were normal, indicating a non-toxic activity of SBH [41]. Another study evaluated the stability of SBH added in culture media and its proliferative effect on dental pulp stem cells (DPSCs). The results showed that SBH added to the culture media for three days resulted in a dose-dependent proliferative effect on DPSCs [35]. Another recent study by Ahmad et al. has evaluated anticancer effects of SBH on malignant glioma (U-87) cells [33]. By using cell proliferation and cells death assays, the authors demonstrated that SBH’s cytotoxic effect on this glioma cell line was time and dose-dependent. SBH also induced nuclear shrinkage, chromatin condensation and nucleus fragmentation, indicating that cellular changes were consistent with the apoptotic characteristics of the cells [33]. Taken together, these studies show exciting initial observations indicating that SBH may serve as a potential therapy for cancers and prompts the need for further investigation.

3.5. Antimicrobial Activity of SBH

Another potential exciting use of SBH could be in the context of antimicrobial activity. It was reported that SBH has a broad-spectrum of antimicrobial effects against four types of Gram-positive bacteria: Bacillus subtilis, Micrococcus luteus, Bacillus megaterium and Bacillus brevis, as well as two Gram-negative bacteria: Escherichia coli and Pseudomonas syringae [47]. These observations were further corroborated by Massaro et al., who studied the antibactericidal effects of a Tetragonula carbonaria honey on Staphylococcus aureus and Klebsiella pneumoniae. These bactericidal effects were attributed to the high concentrations of hydrogen peroxide and phenolic extracts in SBH as measured by gas chromatography-mass spectrometry [43]. Although the number of studies on Apis mellifera honey was significantly higher than those on SBH, several SBH types have been tested and presented higher antioxidant and biological activities, and relatively higher antimicrobial activity against fungus (Candida albicans), Gram-negative (E. coli, K. pneumoniae and Salmonella typhimurium) and Gram-positive (S. aureus, Listeria monocytogenes and Bacillus cereus) bacteria, respectively [30].
Another characteristic of SBH resides in the lower invertase (breaks down sucrose into fructose and glucose) and sucrose levels than A. mellifera honey, which has been suggested to have a strong inhibitory effect on four Gram-positive bacteria: B. subtilis, M. luteus, B. megaterium and B. brevis, and two Gram-negative bacteria: E. coli and P. syringae [48]. These findings were supported by another study that compared the antimicrobial inhibitory effects of Ethiopian SBH, A. mellifera honey and the most common antibiotics (vancomycin, tetracycline, kanamycin, ampicillin and methicillin) against E. coli, S. aureus and K. pneumonia [9]. Interestingly, this study has shown that the inhibitory effects of SBH against all these bacterial strains were stronger than the effects of A. mellifera honey and the antibiotics tested. Altogether, these interesting results suggest that SBH can be a promising candidate towards novel treatments for inflammatory conditions dependent on microbial growth. The microorganisms that have, so far, been examined following treatment with SBH are summarized in Figure 9.
Potent novel antimicrobials are also of interest to treat biofilms. The antibiofilm properties of a total of 57 SBHs were examined along with Medihoney® (an antibacterial wound gel) as a reference and showed an inhibitory effect on biofilm formation in one species of honey, Tetragonisca angustula [40]. In addition, the identified honeys were able to destroy a S. aureus biofilm, mediated by two proteins, T. angustula biofilm destruction factor-1 (TABDF-1) and TABDF-2 [40]. These results indicate that certain honey species may be suited to develop for anti-biofilm applications and even novel wound dressings for specific (i.e., S. aureus) infections. In another study using S. aureus infected wounds, SBH (Trigona) was shown to synergize with the antibiotic ampicillin to inhibit S. aureus [37]. There was also higher bactericidal activity in the combined treatment, compared to either agent alone, including antibiotic-resistant strains [37].

3.6. Other Promising Properties of SBH

In addition to the conventional common properties of SBH that were mentioned above, a recent study showed that one of the components of SBH (i.e., phenylalanine) may be able to trigger the upregulation of brain-derived neurotrophic factor (BDNF) and inositol 1,4,5-triphosphate receptor type 1 (ITPR1) [26], which are genes involved in synaptic function [77,78]. Therefore, SBH displayed capabilities in improving spatial working memory, spatial reference memory and memory consolidations. Another study also suggested that SBH improves memory and reduces anxiety, in addition to its potential to reduce triglyceride, LDL, and normalize blood glucose in rats with metabolic syndrome [24].
As SBH is a good source of natural antioxidants, it was investigated as a potential anti-ageing skin treatment in human dermal fibroblast cells [27]. In this study, treatment with SBH upregulated collagen expression in both ageing and senescent (aged) fibroblast cells, and downregulated matrix metalloproteinase associated with degrading collagen, suggesting SBH may be a promising anti-ageing skin treatment may [27]. Interestingly, all of these recently discovered properties of SBH are from the Malaysian SBH (Kelulut) and during the last year.

3.7. SBH Production in Malaysia

In 2000, Malaysia produced only 5 percent of the countries honey needs, which is considered a trivial estimate compared with Malaysia’s abundant nectar resources [79]. In 2010, by providing sufficient aid, Malaysia managed to increase farm production to 284% of the countries honey needs [79]. Moreover, an immediate shift from popular Tualang (Apis dorsata) honey to SBH observed to be associated with successful domestication of stingless bees and an invention of a commercial MUSTAFA-Hive [80]. The hive is very well-structured; it has become easier to directly collect fresh, hygienic SBH from an intensive farm with systematic locking that protects the hives [80]. We estimated that using the MUSTAFA-hive in Malaysian stingless bee farms improves the implementation of standard operating procedure (SOP) in commercial meliponiculture, and also promote exploring the benefits of SBH in medical research. At present, 15 out of 26 studies on the medicinal properties of SBH around the world were conducted in Malaysia over the past 4 years (Table 1). However, there is still a continuous increase in honey imports, mainly from Australia, New Zealand, China and Iran [81]. Meanwhile, a significant and continuous decrease in honey exports was also reported in 2010–2017 [79]. Although Malaysian stingless bee honey is cost-effective, it is facing export restrictions due to its moisture content which is higher than the amount allowed according to the CODEX Standard 12-1981 (not more than 20 percent) [82]. Therefore, it is important to utilize the unique physiochemical characteristics of Malaysian SBH to increase demand and market value of the honey via different methods. This could also help the beekeepers to increase and sustain their income, and promote SBH as a promising future Malaysian commodity.

4. Stingless Bee Propolis (SBP)

Propolis (a resin-like substance, colloquially known as bee glue) is a substance that bees produce by mixing salivary secretions, beeswax, pollen and other resins harvested from botanical sources, mainly trees [83]. Additionally, geopropolis is a type of less malleable propolis only produced by some stingless bee species (for example, Melipona fasciculata and Melipona quadrifasciata anthidioides) and it is mixed with additional material (soil or clay) [76]. The benefits of SBP have been known for centuries and well-studied, similarly to SBH, and has shown four main medicinal properties; antioxidant, anti-inflammatory, anticancer and antimicrobial activities (Table 2). In addition, SBP has shown promising regenerative capacity, also making it a potential novel therapy for wound healing [74,83]. Although SBP is not as common as A. mellifera propolis, studies have also shown that SBP has higher antimicrobial activities [84]. The potential mechanisms of action of SBP and other stingless bee products are similar to those proposed in the previous sections for SBH.

4.1. Antioxidant Activity of SBP

Similar to SBH, high levels of flavonoids, phenolic acids and terpenoids have been identified in the SBP extracts, which showed promising antioxidant and antimicrobial activity [86,96]. A total of 51 phenolic compounds have been reported in SBP from Melipona subnitida [119]. M. fasciculate geopropolis was found to contain 11 compounds, mostly phenolic acids and hydrolyzable tannins, responsible for the antioxidant activity [103]. The major phenolic compounds that have been reported in different types of SBP are summarized in Figure 10.
Ethanol extracts of SBP showed antioxidant activity as they were able to scavenge free radicals in vitro and also protected erythrocytes by inhibiting oxidative hemolysis [51]. Despite some controversial reports regarding the toxic potential of SBP, Levinas et al. have performed in silico toxicity analysis involved a total of 35 SBP phenolic compounds [17]. The analysis showed that these compounds revealed low toxicity, which means that SBP is safe and not considered as a toxic product, whereas more pre-clinical studies are still required to confirm these findings.

4.2. Anticancer Activity of SBP

Cytotoxic activity, specifically necrosis, has been induced by SBP extracts in leukemic cell lines [51]. Apoptotic cytotoxicity has also been observed in different cancer cell lines (breast, colon, epithelial colorectal and melanoma) when treated with SBP extracts [108]. Furthermore, a dichloromethane extract of SBP displayed cytotoxic effects on head and neck squamous cell carcinoma (HNSCC) cell lines, resulting in reduced viability of these cells [94]. Novel compounds, 27-hydroxyisomangiferolic acid and 23-hydroxyisomangiferolic acid B, in the SBP extract displayed the highest levels of cytotoxicity against pancreatic cancer cells [95]. Further cytotoxic effects of SBP against canine osteosarcoma cells have been reported, with modulated cell morphologies and reduced viability of the cancer cells observed [109]. Another study found out that the piperidinic alkaloids together with C-glycopyranoside flavonoids in SBP extract were associated with apoptosis in melanoma cells, as well as inhibition of migration and invasion of these cells [90]. Further, SBP extracts demonstrated antiproliferative activity against cancer cell lines (colon, breast, hepatic and stomach), but did not affect normal cell lines (liver and fibroblasts) [107,113]. In studies mimicking the angiogenic micro-environment related to tumor development, SBP extracts demonstrated a cytotoxic effect and anti-angiogenic activity on the vascular cells [89].
Moreover, cardol (5-pentadecyl resorcinol) was the major compound identified in a fraction of SBP, exhibiting cytotoxicity against human colon, liver, gastric, lung, and breast cancer cell lines [102]. Thus, SBP has potent in-vitro anticancer activity, shown by the induction of apoptosis, and cell cycle arrest in these cell lines [102]. Kustiawan et al. also found that cardol isolated from SBP has been used to treat human colorectal adenocarcinoma cell lines, induced changes in cell morphology, increased the expression of apoptotic proteins (caspase-3 and caspase-9) and also cleavage of pro-caspase-3, pro-caspase-9 and poly (ADP-ribose) polymerase (PARP) [92]. Therefore, cardol isolated from SBP can induce cancer-induced cell death and could be a potential candidate for developing as an additional cancer therapy.

4.3. Anti-Inflammatory Activity of SBP

Due to their anti-inflammatory properties, SBP extracts have been used in the treatment of a murine asthma model [106]. In this model, rats treated with SBP had reduced progression of allergic inflammation as shown by decreased total cell counts in the bronchoalveolar fluid, decreased peribronchovascular inflammation and inhibition of polymorphonuclear cells into the alveolar spaces [106]. This study showed comparable anti-inflammatory effects of SBP to the positive control treatment, dexamethasone [106]. Additionally, SBP has been reported to have antinociceptive activity (inhibition of pain) due to decreased IL-1β and TNF-α [111]. Other studies have shown similar cytokine-mediated anti-inflammatory effects, as SBP extracts decreased IL-6 expression on inflamed dental pulp tissues [93].
Interestingly, different potential properties of SBP have been examined together in studies conducted by Campos et al. [99,105]. They showed that SBP has antimicrobial activity against Gram-positive and Gram-negative bacteria and fungus, as well as antioxidant activity by suppressing oxidation-induced erythrocytes hemolysis and lipid degradation [99,105]. They also reported anti-inflammatory activity by inhibition of the hyaluronidase enzyme, and necrotic cytotoxic activity against leukemia cell lines [99,105]. Another comparable study by Umthong et al. also showed the antimicrobial activities of SBP, against Gram-positive and Gram-negative bacteria and fungus, as well as antiproliferative cytotoxic activities resulting in an increase in cell death by necrosis in colon cancer cells [115].

4.4. Antimicrobial Activity of SBP

SBP has known antimicrobial activity against numerous microorganisms. SBP extracts have displayed potent broad-spectrum antimicrobial activity against Gram-positive bacterial (S. aureus, Enterococcus faecalis, M. luteus, Streptococcus mutans and B. subtilis), Gram-negative bacterial (E. coli and Pseudomonas aeruginosa), and yeast (Cryptococcus neoformans and C. albicans), either significantly stronger or equivalent to standard antibiotics [88,96,98,104,112,114,116].
It was reported that SBP is rich with cycloartane compounds in high enough levels to produce high antioxidant activity, which resulted in inhibitory activity against yeast α-glucosidase [87]. In addition to the antioxidant properties shown by inhibition of inflammatory enzymes [87], SBP also decreased the mutagenesis in yeast cells (Saccharomyces cerevisiae) [96]. In the same study, SBP extracts were more effective against gram-positive bacteria than gram-negative bacteria [96]. Furthermore, extracts of SBP demonstrated antibiofilm and antibacterial activities, by inhibiting reduced S. mutans growth and adherence [97]. Another study found that one of the extracted components from SBP is α-mangostin [97]. The α-mangostin (likely collected from Mangosteen) exhibited a strong antibacterial effect against both gram-positive and gram-negative bacteria, with Staphylococcus epidermidis being the most sensitive [100]. Similarly, the high concentrations of diterpenic acids in one extract of SBP were associated with cytotoxic activity against Staphylococcal aureus, but not against E. coli or C. albicans [93,106,109]. Another study has shown that cinnamoyloxy-mammeisin isolated from SBP has antimicrobial, anti-adherence and anti-biofilm activity against S. aureus [85].
Although SBP is not as commonly known for its antimicrobial properties as propolis from honey bees, Pino et al. have shown that the SBP from Melipona beecheii have higher content of trans-verbenol, α-copaene, β-caryophyllene, β-bourbonene, α-pinene, spathulenol, β-pinene and caryophyllene oxide compared to propolis from A. mellifera, despite both being collected from one region (Yucatán, Mexico) with similar natural flora [120]. These chemical compounds are known as potential antimicrobial agents [121,122].

5. Stingless Bee Cerumen

Cerumen is a mixture of propolis with the wax secreted by stingless bees before they use it for nest construction [123]. Only a few studies have been conducted, in the last decade, on stingless bee cerumen and pollen (Table 3). It has been reported that stingless bee cerumen extracts have anti-inflammatory potential as they are capable of inhibiting enzymes responsible for catalyzing the activity of pro-inflammatory mediators [124]. In this study, cerumen extracts were comparable to that of the positive control, Trolox (an antioxidant like vitamin E), though less inhibitory than honeybee propolis [124].
Stingless bee cerumen extracts have also been used as a potential anticancer agent with human breast, lung, liver, stomach and colon cancer cell lines, inducing high cytotoxicity and an apoptotic like cell morphology [15]. This study also showed that α-mangostin isolated from cerumen induced in vitro cytotoxicity against the above cell lines and in-vivo cytotoxicity against zebrafish embryos [15].

6. Stingless Bee Pollen

Barbara et al. reported desirable nutritional properties for bee pollen extracts collected from stingless bees [130]. These extracts were reported to contain polyphenols, flavonoids and fatty acids, suggesting the antioxidant potential of stingless bee pollen [126,130]. These findings have been supported by a recent study on eight stingless bee pollen samples from different regions in the Philippines [127]. The most common phenolic compounds in stingless bee pollen are summarized in Figure 11.
There was no evidence of microbial contamination in the bee pollens examined, including E. coli, Salmonella, S. aureus, Coliforms, and Clostridia, though mesophilic microorganisms were detected [124]. Another study has shown stingless bee pollen extracts have anti-inflammatory effects by reducing mouse footpad edema and also decreasing evidence of a pain (antinociceptive) response following administration of acetic acid [130]. A recent study suggested that the anti-inflammatory effect of stingless bee pollen results from its antioxidant activity that inhibits cyclooxygenase (COX), which promotes inflammation by producing prostaglandins [126]. Furthermore, a study to detect the synergistic effect of stingless bee pollen extracts with cisplatin (a chemotherapeutic drug) on breast cancer cells showed antioxidant and antiproliferative effects of bee pollen against the cancer cells [129]. The combination of bee pollen extracts and cisplatin further reduced the proliferation of the cancer cells, compared to cisplatin alone [129]. Therefore, stingless bee pollen extracts are a potential novel cancer therapeutic agent and may be useful as an additive treatment option for chemotherapy.

7. Comparison of Stingless Bee Products and Their Health Benefits

Only a few studies have directly compared the potential medicinal properties of stingless bee products (Table 4). In a study by Ismail et al., each of SBH, SBP, and beebread (fermented bee pollen by lactic ferments [131]) extracts were compared for their antioxidant and anticancer effects [16]. SBP, SBH and beebread all contained phenolic content and displayed antioxidant capacity relating to the levels of phenolic content, respectively, with SBP showing the highest antioxidant capacity [16]. Additionally, treatment with SBP showed the highest growth inhibition in human breast adenocarcinoma cells, compared to SBH and beebread extracts, respectively [16]. Another study examined the cytotoxic activity of crude extracts of SBP, SBH, and bee pollen from different stingless bee species against human breast, lung, liver, gastric and colon cancer cell lines [14]. The SBP and SBH showed higher cytotoxic activities than bee pollen, with SBP exhibiting the highest overall cytotoxic activity against all cell lines, particularly from bee species T. incisa and Trigona fuscobalteata [14]. Furthermore, the potential immunomodulatory effect of SBP and SBH has been examined in a murine S. typhi infection model [129]. Both SBH and SBP increased FoxP3 mRNA expression (transcription factor of regulatory T cells) following infection, with the highest increase seen in the SBP treated group [132].

8. Bacterial Isolates from Stingless Bee Products

The bacterial species isolated from different stingless bee products have also been investigated. In a study which isolated and phenotypically characterized 41 different bacterial species from SBH, SBP and beebread, Bacillus were the predominant species found [128]. Proteolytic, lipolytic and cellulolytic extracellular enzyme activities were detected in four non-pathogenic bacterial isolates (Bacillus amyloliquefaciens, Bacillus safensis, Bacillus stratosphericus and B. subtilis) [133]. B. amyloliquefaciens isolates showed the highest antimicrobial activity against Gram-positive and Gram-negative bacteria [133]. Another study isolated a total of 51 symbiotic actinobacteria from stingless bees (their pollen, honey, garbage pellets and cerumen), then characterized their antibacterial effects against pathogenic human microorganisms [134]. Half of the isolates identified displayed antimicrobial activity to Gram-positive bacteria or fungi, some inhibited both, and most antibacterial isolates were from the Streptomyces species [132]. This study outlines the benefits to the colony, and potential human therapeutic benefits, of stingless bees acquiring actinobacteria from the areas they pollinate.

9. Biological Activity and Targets of Phenolic Compounds

As it is shown in the above sections, studies have discovered a variety of biological activities of stingless bee products and their compounds, while the mechanisms of action for these activities are less studied. However, the biological targets for the compounds of stingless bee products can be presumed based on previous studies on other natural products that contain similar compounds. The role of antioxidant phenolic compounds in the process of radical scavenging, to prevent damage of cellular components (diseases), has been discovered, while their antimicrobial activities still not clear. In addition to the enzymatic antioxidants that neutralize free radicals by transforming them to stable molecules (Figure 4), there are non-enzymatic antioxidants (e.g., phenolic compounds and ascorbic acid) that not only interrupt the chain reaction caused by free radicals but also can inhibit the formation of free radicals [7]. Studies on plant antimicrobial compounds showed that some of the common phenolic compounds that existed in stingless bee products, especially SBH, have strong antimicrobial potency (Table 5). These insights open the door for researchers to study the mechanisms of action for novel antimicrobial compounds in stingless bee products.
On the other hand, ascorbic acid (vitamin C) is a well-known antioxidant able to block the lipid peroxidation chain reaction by transforming an unpaired electron to the lipid radical (Figure 12). A study on the Afrotropical SBH produced by Hypotrigona sp. showed that this SBH is rich in ascorbic acid (161.69 ± 6.70 mg/kg) and has higher antioxidant properties than A. mellifera honey [12]. While a variety of immunomodulatory and antimicrobial properties have been suggested for ascorbic acid, studies to assess its content in stingless bee products are still required, and its antimicrobial mechanisms of action need better understanding. Furthermore, there is a gap of knowledge about the content of other potential antioxidants, such as carotenoids and tocopherol, in stingless bee products and their potential medicinal properties.

10. Future Directions

There is still a lack of comprehensive studies to evaluate the antioxidant potentials, quantum-chemical and molecular docking analysis of the major phenolic compounds present in each of stingless bee products. For example, a study by Fujishima et al. showed that both quercetin and gallic acid, from leaves and bark extracts of Curatella americana Linn, are important inhibitors of XO enzyme through its interactions with specific amino acid residues at the activity site of XO [144]. This type of studies is essential to understand the antioxidant potential of each phenolic compound with mechanisms of action. Honey is the best known primary product of stingless bees in terms of purity and availability, whereas other stingless bee products are less common, therefore here we focus on SBH and its promising opportunities.
Stingless bee species produce honey with different metabolite profiles, presenting a diverse range of biological mechanisms for the benefits of human health [145,146]. It was suggested that honey bees are the best model for gut microbiota research [147]. The gut microbiota of the honey bee provides advantages in terms of studying the systems that determine gut community composition and dynamics, as well as addressing how gut communities impact their hosts [147]. On the other hand, Razali et al. showed that the metabolite contents of the honey were varied due to different stingless bee species that might secrete different types of enzymes to the foraged nectar [146]. This was supported by Kek et al. [145], who stated that the composition of honey was probably affected by the type of bee because the honey-making process is highly dependent on the enzymes added by the bees. Since the symbiotic bacteria of insects have received increasing attention due to their prominent roles in the provision of nutrients and modulating host responses, there is a need to study the contribution of stingless bee microbial communities to the metabolites profiles and immunotherapeutic potential of their honey extracts.
Furthermore, nanoparticles show a promising role in controlling immune homeostasis during several inflammatory conditions [70,74,148]. Compared to the chemical synthesis for nanoparticles, the green synthesis (i.e., using natural products) provides advancement due to it is safer for the therapeutic intervention purposes and environment-friendly [149,150]. Although honey mediated green synthesis has been used before [151], no studies to date have utilized SBH in this process. While Kothai and Jayanthi have synthesized silver nanoparticles using SBP mediated green synthesis, and the produced nanoparticles exhibited significant anticancer activity against human lung cancer cells [101]. Therefore, it is important to study the efficiency of SBH too in the green synthesis for nanoparticles used as a treatment. Furthermore, we hypothesis that using SBH in nano-size formulations as an immune booster would be a promising approach for inflammatory-based conditions in the future. Since previous studies have shown that the effective nanoparticle size to target immune cells is approximately 50 nm [152,153], producing SBH in 50 nm size would be a novel and efficient targeting strategy for modulating the immune response in the inflammatory models including cancer microenvironment.
Additionally, information regarding the potential health benefits of SBH in medical databases is still scarce, as well as how stingless bees’ gut microbiome diversity affects the honey that they produce. In recent years, studies have focused on the importance of symbiotic bacteria due to their prominent role in nutrient acquisition and immune responses [154,155]. These bacterial communities have been best characterized in worker bees [156] and thought to consist of a core group of bacterial clades in which three major bacterial phyla (Proteobacteria, Firmicutes and Actinobacteria) have been found to dominate the honey bee microbiome [157,158]. Despite maintaining colony homeostasis and fitness, the contribution of their microbial communities to the metabolites profiles and immunotherapeutic properties of their extracted honey is mainly unknown. Therefore, future studies should aim to bridge this gap by focusing on the gut microbiome diversity of stingless bee species using a metagenomics approach.
Therefore, we strongly encourage future studies to perform a comprehensive metagenomics analysis on the best SBH producer species to select those capable of producing high-quality SBH with desirable properties; based on their gut microbiome. Then, it is important to do metabolomics analysis for the produced SBH, to ensure whether the expected properties exist, before proceeding towards the production of SBH in nano-size and utilize it against different inflammatory illnesses.

11. Conclusions

It is known that all bee products are rich with compounds that provide high nutritional and medicinal properties. However, not all bee types have been equally studied, with limited knowledge about stingless bee products compared to other honey producers. This work provides a comprehensive review of all the medicinal properties of stingless bee products that have been explored to date. To the best of our knowledge, this is the first review that addresses all these data together. The present review also provides new promising insights to improve SBH research and to achieve more utilization for its medicinal properties. In general, despite exhibiting its tremendous medicinal properties, honey has still been abandoned and disregarded in the modern pharmaceutical era and only classified under complementary medicine. Way forward, rather than treatment approach, honey should be redefined as a potential agent for disease prevention, as measured by its antioxidant properties and effectiveness in manipulating the signaling pathways in the progression of disease.

Author Contributions

Conceptualization, M.A.I.A.-H., R.M. and M.Z.M.; writing—original draft preparation, M.A.I.A.-H.; writing—review and editing, J.C.B., K.L.W., M.P., R.M. and M.Z.M.; supervision, R.M. and M.Z.M.; funding acquisition, M.Z.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by “Research University Incentive Grant, grant number USM/1001/PPSP/8012252”, “Malaysian Research University Network Grant, grant number USM/304/PPSP/656201/K145” and “Translational Research Grant Scheme by Ministry of Education Malaysia, grant number USM/203/PPSP/6171205”.

Acknowledgments

The first author (M.A.I.A.-H.) would like to acknowledge Universiti Sains Malaysia (USM) Fellowship Scheme for providing financial support.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the work; in the writing of the manuscript, or in the decision to publish it.

References

  1. Bradbear, N. Bees and Their Role in Forest Livelihoods: A Guide to the Services Provided by Bees and the Sustainable Harvesting, Processing and Marketing of Their Products; Food and Agriculture Organization of the United Nations: Rome, Italy, 2009. [Google Scholar]
  2. Samarghandian, S.; Farkhondeh, T.; Samini, F. Honey and Health: A Review of Recent Clinical Research. Pharmacogn. Res. 2017, 9, 121–127. [Google Scholar] [CrossRef]
  3. Michener, C.D. The meliponini. In Pot-Honey; Vit, P., Pedro, S.R., Roubik, D., Eds.; Springer: New York, NY, USA, 2013; pp. 3–17. [Google Scholar]
  4. Crane, E. The Past and Present Status of Beekeeping with Stingless Bees. Bee World 1992, 73, 29–42. [Google Scholar] [CrossRef]
  5. Rattanawannee, A.; Duangphakdee, O. Southeast Asian Meliponiculture for Sustainable Livelihood. In Modern Beekeeping—Bases for Sustainable Production; IntechOpen: London, UK, 2019. [Google Scholar]
  6. Michener, C. The Bees of the World; John Hopkins University Press: Baltimore, MD, USA, 2000. [Google Scholar]
  7. Abd Jalil, M.A.; Kasmuri, A.R.; Hadi, H. Stingless Bee Honey, the Natural Wound Healer: A Review. Skin Pharmacol. Physiol. 2017, 30, 66–75. [Google Scholar] [CrossRef] [PubMed]
  8. Chuttong, B.; Chanbang, Y.; Sringarm, K.; Burgett, M. Physicochemical profiles of stingless bee (Apidae: Meliponini) honey from South East Asia (Thailand). Food Chem. 2016, 192, 149–155. [Google Scholar] [CrossRef] [PubMed]
  9. Ewnetu, Y.; Lemma, W.; Birhane, N. Antibacterial effects of Apis mellifera and stingless bees honeys on susceptible and resistant strains of Escherichia coli, Staphylococcus aureus and Klebsiella pneumoniae in Gondar, Northwest Ethiopia. BMC Complement. Altern. Med. 2013, 13, 269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Fuenmayor, C.A.; Díaz-Moreno, A.C.; Zuluaga-Domínguez, C.M.; Quicazán, M.C. Honey of Colombian stingless bees: Nutritional characteristics and physicochemical quality indicators. In Pot-Honey; Vit, P., Pedro, S.R., Roubik, D., Eds.; Springer: New York, NY, USA, 2013; pp. 383–394. [Google Scholar]
  11. Brown, E.; O’Brien, M.; Georges, K.; Suepaul, S. Physical characteristics and antimicrobial properties of Apis mellifera, Frieseomelitta nigra and Melipona favosa bee honeys from apiaries in Trinidad and Tobago. BMC Complement. Med. Ther. 2020, 20, 85. [Google Scholar] [CrossRef] [Green Version]
  12. Nweze, J.A.; Okafor, J.I.; Nweze, E.I.; Nweze, J.E. Evaluation of physicochemical and antioxidant properties of two stingless bee honeys: A comparison with Apis mellifera honey from Nsukka, Nigeria. BMC Res. Notes 2017, 10, 566. [Google Scholar] [CrossRef] [Green Version]
  13. Zulkhairi Amin, F.A.; Sabri, S.; Mohammad, S.M.; Ismail, M.; Chan, K.W.; Ismail, N.; Norhaizan, M.E.; Zawawi, N. Therapeutic Properties of Stingless Bee Honey in Comparison with European Bee Honey. Adv. Pharmacol. Sci. 2018, 2018, 6179596. [Google Scholar] [CrossRef]
  14. Kustiawan, P.M.; Puthong, S.; Arung, E.T.; Chanchao, C. In vitro cytotoxicity of Indonesian stingless bee products against human cancer cell lines. Asian Pac. J. Trop. Biomed. 2014, 4, 549–556. [Google Scholar] [CrossRef] [Green Version]
  15. Nugitrangson, P.; Puthong, S.; Iempridee, T.; Pimtong, W.; Pornpakakul, S.; Chanchao, C. In vitro and in vivo characterization of the anticancer activity of Thai stingless bee (Tetragonula laeviceps) cerumen. Exp. Biol. Med. 2016, 241, 166–176. [Google Scholar] [CrossRef] [Green Version]
  16. Ismail, W.I.W.; Hussin, N.N.; Mazlan, S.N.F.; Hussin, N.H.; Radzi, M.N.F.M. Physicochemical Analysis, Antioxidant and Anti Proliferation Activities of Honey, Propolis and Beebread Harvested from Stingless Bee. In Proceedings of the IOP Conference Series: Materials Science and Engineering, Vanderbijlpark, South Africa, 23–26 October 2018; p. 012048. [Google Scholar]
  17. Lavinas, F.C.; Macedo, E.H.B.; Sá, G.B.; Amaral, A.C.F.; Silva, J.R.; Azevedo, M.; Vieira, B.A.; Domingos, T.F.S.; Vermelho, A.B.; Carneiro, C.S. Brazilian stingless bee propolis and geopropolis: Promising sources of biologically active compounds. Rev. Bras. Farmacogn. 2019, 29, 389–399. [Google Scholar] [CrossRef]
  18. Syafrizal, A.A.; Sila, M.; Marji, D. Diversity of kelulut bee (Trigona spp.) in Lempake education forest. Mulawarman Sci. 2012, 11, 11–18. [Google Scholar]
  19. Sommeijer, M.J. Beekeeping with stingless bees: A new type of hive. Bee World 1999, 80, 70–79. [Google Scholar] [CrossRef]
  20. Reid, G. Honey from Stingless Bees. Available online: https://www.meliponinibeehoney.com/blog/honey-from-stingless-bees (accessed on 27 May 2020).
  21. Souza, B.A.; Roubik, D.W.; Barth, O.M.; Heard, T.A.; Enríquez, E.; Carvalho, C.; Villas-Bôas, J.; Marchini, L.; Locatelli, J.; Persano-Oddo, L. Composition of stingless bee honey: Setting quality standards. Interciencia 2006, 31, 867–875. [Google Scholar]
  22. Menezes, C.; Vollet Neto, A.; Fonseca, V.L.I. A method for harvesting unfermented pollen from stingless bees (Hymenoptera, Apidae, Meliponini). J. Apic. Res. 2012, 51, 240–244. [Google Scholar] [CrossRef]
  23. Department of Standards Malaysia. Kelulut (Stingless bee) honey-Specification, MS 2683. 2017. Available online: https://www.scribd.com/document/398215369/Kelulut-Stingless-bee-honey-Specification (accessed on 27 May 2020).
  24. Arshad, N.; Lin, T.S.; Yahaya, M.F. Stingless bee honey reduces anxiety and improves memory of the metabolic disease-induced rats. CNS Neurol. Disord. Drug Targets 2020. [Google Scholar] [CrossRef]
  25. Biluca, F.C.; da Silva, B.; Caon, T.; Mohr, E.T.B.; Vieira, G.N.; Gonzaga, L.V.; Vitali, L.; Micke, G.; Fett, R.; Dalmarco, E.M.; et al. Investigation of phenolic compounds, antioxidant and anti-inflammatory activities in stingless bee honey (Meliponinae). Food Res. Int. 2020, 129, 108756. [Google Scholar] [CrossRef]
  26. Mustafa, M.Z.; Zulkifli, F.N.; Fernandez, I.; Mariatulqabtiah, A.R.; Sangu, M.; Nor Azfa, J.; Mohamed, M.; Roslan, N. Stingless Bee Honey Improves Spatial Memory in Mice, Probably Associated with Brain-Derived Neurotrophic Factor (BDNF) and Inositol 1,4,5-Triphosphate Receptor Type 1 (Itpr1) Genes. Evid. Based Complement. Alternat. Med. 2019, 2019, 8258307. [Google Scholar] [CrossRef] [Green Version]
  27. Abdul Malik, N.; Mohamed, M.; Mustafa, M.Z.; Zainuddin, A. In vitro modulation of extracellular matrix genes by stingless bee honey in cellular aging of human dermal fibroblast cells. J. Food Biochem. 2019, 44, e13098. [Google Scholar] [CrossRef]
  28. Hazirah, H.; Yasmin, A.M.; Norwahidah, A. Antioxidant Properties of Stingless Bee Honey and Its Effect on the Viability of Lymphoblastoid Cell Line. Med. Health 2019, 14, 91–105. [Google Scholar] [CrossRef]
  29. Al Kafaween, M.A.; Hilmi, A.B.M.; Khan, R.S.; Bouacha, M.; Amonov, M. Effect of Trigona honey on Escherichia coli cell culture growth: In vitro study. J. Apither. 2019, 5, 10–17. [Google Scholar] [CrossRef]
  30. Avila, S.; Hornung, P.S.; Teixeira, G.L.; Malunga, L.N.; Apea-Bah, F.B.; Beux, M.R.; Beta, T.; Ribani, R.H. Bioactive compounds and biological properties of Brazilian stingless bee honey have a strong relationship with the pollen floral origin. Food Res. Int. 2019, 123, 1–10. [Google Scholar] [CrossRef] [PubMed]
  31. Selvaraju, K.; Vikram, P.; Soon, J.M.; Krishnan, K.T.; Mohammed, A. Melissopalynological, physicochemical and antioxidant properties of honey from West Coast of Malaysia. J. Food Sci. Technol. 2019, 56, 2508–2521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Ranneh, Y.; Akim, A.M.; Hamid, H.A.; Khazaai, H.; Fadel, A.; Mahmoud, A.M. Stingless bee honey protects against lipopolysaccharide induced-chronic subclinical systemic inflammation and oxidative stress by modulating Nrf2, NF-kappaB and p38 MAPK. Nutr. Metab. 2019, 16, 15. [Google Scholar] [CrossRef]
  33. Ahmad, F.; Seerangan, P.; Mustafa, M.Z.; Osman, Z.F.; Abdullah, J.M.; Idris, Z. Anti-Cancer Properties of Heterotrigona itama sp. Honey Via Induction of Apoptosis in Malignant Glioma Cells. Malays. J. Med. Sci. 2019, 26, 30–39. [Google Scholar] [CrossRef]
  34. Mohd Rafie, A.Z.; Syahir, A.; Wan Ahmad, W.A.N.; Mustafa, M.Z.; Mariatulqabtiah, A.R. Supplementation of Stingless Bee Honey from Heterotrigona itama Improves Antiobesity Parameters in High-Fat Diet Induced Obese Rat Model. Evid. Based Complement. Altern. Med. 2018, 2018, 6371582. [Google Scholar] [CrossRef] [Green Version]
  35. Mohamad, M.A.M.; Mazlan, M.A.; Ibrahim, M.; Yusof, A.M.; Shamsuddin, S.A.A.; Hassan, N.F.N.; Muhammad, H.; Isa, M.L.M. The effect of Malaysian stingless bee, Trigona spp. honey in promoting proliferation of the undifferentiated stem cell. Asia Pac. J. Mol. Biol. Biotechnol. 2018, 27, 10–19. [Google Scholar] [CrossRef]
  36. Nordin, A.; Omar, N.; Sainik, N.Q.A.V.; Chowdhury, S.R.; Omar, E.; Saim, A.B.; Idrus, R.B.H. Low dose stingless bee honey increases viability of human dermal fibroblasts that could potentially promote wound healing. Wound Med. 2018, 23, 22–27. [Google Scholar] [CrossRef]
  37. Ng, W.-J.; Lye, P.-Y.; Chan, Y.-J.; Lau, Z.-K.; Ee, K.-Y. Synergistic effect of trigona honey and ampicillin on Staphylococcus aureus isolated from infected wound. Int. J. Pharmacol. 2017, 13, 403–407. [Google Scholar] [CrossRef] [Green Version]
  38. Aziz, M.S.A.; Giribabu, N.; Rao, P.V.; Salleh, N. Pancreatoprotective effects of Geniotrigona thoracica stingless bee honey in streptozotocin-nicotinamide-induced male diabetic rats. Biomed. Pharmacother. 2017, 89, 135–145. [Google Scholar] [CrossRef]
  39. Budin, S.B.; Jubaidi, F.F.; Azam, S.N.F.M.N.; Yusof, N.L.M.; Taib, I.S.; Mohamed, J. Kelulut honey supplementation prevents sperm and testicular oxidative damage in streptozotocin-induced diabetic rats. J. Teknol. 2017, 79. [Google Scholar] [CrossRef] [Green Version]
  40. Zamora, L.G.; Beukelman, C.J.; van den Berg, A.J.; Aerts, P.C.; Quarles van Ufford, H.C.; Nijland, R.; Arias, M.L. An insight into the antibiofilm properties of Costa Rican stingless bee honeys. J. Wound Care 2017, 26, 168–177. [Google Scholar] [CrossRef] [PubMed]
  41. Saiful Yazan, L.; Muhamad Zali, M.F.; Mohd Ali, R.; Zainal, N.A.; Esa, N.; Sapuan, S.; Ong, Y.S.; Tor, Y.S.; Gopalsamy, B.; Voon, F.L.; et al. Chemopreventive Properties and Toxicity of Kelulut Honey in Sprague Dawley Rats Induced with Azoxymethane. Biomed. Res. Int. 2016, 2016, 4036926. [Google Scholar] [CrossRef] [Green Version]
  42. Syam, Y.; Natsir, R.; Rahardjo, S.P.; Usman, A.N.; Dwiyanti, R.; Hatta, M. Effect of Trigona honey to mRNA expression of interleukin-6 on Salmonella Typhi induced of BALB/c mice. Am. J. Microbiol. Res. 2016, 4, 77–80. [Google Scholar] [CrossRef]
  43. Massaro, C.F.; Shelley, D.; Heard, T.A.; Brooks, P. In vitro antibacterial phenolic extracts from “sugarbag” pot-honeys of Australian stingless bees (Tetragonula carbonaria). J. Agric. Food Chem. 2014, 62, 12209–12217. [Google Scholar] [CrossRef]
  44. Borsato, D.M.; Prudente, A.S.; Doll-Boscardin, P.M.; Borsato, A.V.; Luz, C.F.; Maia, B.H.; Cabrini, D.A.; Otuki, M.F.; Miguel, M.D.; Farago, P.V.; et al. Topical anti-inflammatory activity of a monofloral honey of Mimosa scabrella provided by Melipona marginata during winter in southern Brazil. J. Med. Food 2014, 17, 817–825. [Google Scholar] [CrossRef]
  45. Ilechie, A.A.; Kwapong, P.K.; Mate-Kole, E.; Kyei, S.; Darko-Takyi, C. The efficacy of stingless bee honey for the treatment of bacteria-induced conjunctivitis in guinea pigs. J. Exp. Pharmacol. 2012, 4, 63–68. [Google Scholar] [CrossRef] [Green Version]
  46. Boorn, K.L.; Khor, Y.Y.; Sweetman, E.; Tan, F.; Heard, T.A.; Hammer, K.A. Antimicrobial activity of honey from the stingless bee Trigona carbonaria determined by agar diffusion, agar dilution, broth microdilution and time-kill methodology. J. Appl. Microbiol. 2010, 108, 1534–1543. [Google Scholar] [CrossRef]
  47. Garedew, A.; Schmolz, E.; Lamprecht, I. Microcalorimetric investigation on the antimicrobial activity of honey of the stingless bee Trigona spp. and comparison of some parameters with those obtained with standard methods. Thermochim. Acta 2004, 415, 99–106. [Google Scholar] [CrossRef]
  48. Torres, A.; Garedew, A.; Schmolz, E.; Lamprecht, I. Calorimetric investigation of the antimicrobial action and insight into the chemical properties of “angelita” honey—A product of the stingless bee Tetragonisca angustula from Colombia. Thermochim. Acta 2004, 415, 107–113. [Google Scholar] [CrossRef]
  49. Patricia, V. Effect of stingless bee honey in selenite induced cataracts. Apiacta 2002, 3, 1–2. [Google Scholar]
  50. Comert, E.D.; Gokmen, V. Evolution of food antioxidants as a core topic of food science for a century. Food Res. Int. 2018, 105, 76–93. [Google Scholar] [CrossRef] [PubMed]
  51. Bonamigo, T.; Campos, J.F.; Alfredo, T.M.; Balestieri, J.B.; Cardoso, C.A.; Paredes-Gamero, E.J.; de Picoli Souza, K.; Dos Santos, E.L. Antioxidant, Cytotoxic, and Toxic Activities of Propolis from Two Native Bees in Brazil: Scaptotrigona depilis and Melipona quadrifasciata anthidioides. Oxid. Med. Cell. Longev. 2017, 2017, 1038153. [Google Scholar] [CrossRef] [Green Version]
  52. Dzialo, M.; Mierziak, J.; Korzun, U.; Preisner, M.; Szopa, J.; Kulma, A. The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders. Int. J. Mol. Sci. 2016, 17, 160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Dharmaraja, A.T. Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. J. Med. Chem. 2017, 60, 3221–3240. [Google Scholar] [CrossRef]
  54. Reinisalo, M.; Karlund, A.; Koskela, A.; Kaarniranta, K.; Karjalainen, R.O. Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases. Oxid. Med. Cell. Longev. 2015, 2015, 340520. [Google Scholar] [CrossRef] [Green Version]
  55. Al-Hatamleh, M.A.I.; Baig, A.A.; Simbak, N.B.; Nadeem, M.I.; Khan, S.U.; Ariff, T.M. Molecular Modulation of Stress Induced to Abnormal Haematological Indices in Medical Students, Malaysian Perspective. Pak. J. Biol. Sci. 2017, 20, 478–488. [Google Scholar] [CrossRef]
  56. Pham-Huy, L.A.; He, H.; Pham-Huy, C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008, 4, 89–96. [Google Scholar]
  57. White, P.A.; Oliveira, R.C.; Oliveira, A.P.; Serafini, M.R.; Araujo, A.A.; Gelain, D.P.; Moreira, J.C.; Almeida, J.R.; Quintans, J.S.; Quintans-Junior, L.J.; et al. Antioxidant activity and mechanisms of action of natural compounds isolated from lichens: A systematic review. Molecules 2014, 19, 14496–14527. [Google Scholar] [CrossRef]
  58. Kek, S.P.; Chin, N.L.; Yusof, Y.A.; Tan, S.W.; Chua, L.S. Total phenolic contents and colour intensity of Malaysian honeys from the Apis spp. and Trigona spp. bees. Agric. Agric. Sci. Procedia 2014, 2, 150–155. [Google Scholar] [CrossRef] [Green Version]
  59. da Silva, I.A.; da Silva, T.M.; Camara, C.A.; Queiroz, N.; Magnani, M.; de Novais, J.S.; Soledade, L.E.; Lima Ede, O.; de Souza, A.L.; de Souza, A.G. Phenolic profile, antioxidant activity and palynological analysis of stingless bee honey from Amazonas, Northern Brazil. Food Chem. 2013, 141, 3552–3558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Biluca, F.C.; de Gois, J.S.; Schulz, M.; Braghini, F.; Gonzaga, L.V.; Maltez, H.F.; Rodrigues, E.; Vitali, L.; Micke, G.A.; Borges, D.L. Phenolic compounds, antioxidant capacity and bioaccessibility of minerals of stingless bee honey (Meliponinae). J. Food Compos. Anal. 2017, 63, 89–97. [Google Scholar] [CrossRef]
  61. Becker, M.M.; Nunes, G.S.; Ribeiro, D.B.; Silva, F.E.P.S.; Catanante, G.; Marty, J.-L. Determination of the Antioxidant Capacity of Red Fruits by Miniaturized Spectrophotometry Assays. J. Braz. Chem. Soc. 2019, 30, 1108–1114. [Google Scholar] [CrossRef]
  62. Rajurkar, N.S.; Hande, S.M. Estimation of phytochemical content and antioxidant activity of some selected traditional Indian medicinal plants. Indian J. Pharm. Sci. 2011, 73, 146–151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Oliveira, R.G.; Jain, S.; Luna, A.C.; Freitas, L.D.; Araujo, E.D. Screening for quality indicators and phenolic compounds of biotechnological interest in honey samples from six species of stingless bees (Hymenoptera: Apidae). Food Sci. Technol. 2017, 37, 552–557. [Google Scholar] [CrossRef] [Green Version]
  64. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018, 9, 7204–7218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.; Rahu, N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid. Med. Cell. Longev. 2016, 2016, 7432797. [Google Scholar] [CrossRef] [Green Version]
  66. Yahfoufi, N.; Alsadi, N.; Jambi, M.; Matar, C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients 2018, 10, 1618. [Google Scholar] [CrossRef] [Green Version]
  67. Arulselvan, P.; Fard, M.T.; Tan, W.S.; Gothai, S.; Fakurazi, S.; Norhaizan, M.E.; Kumar, S.S. Role of Antioxidants and Natural Products in Inflammation. Oxid. Med. Cell. Longev. 2016, 2016, 5276130. [Google Scholar] [CrossRef] [Green Version]
  68. Roy, J.; Galano, J.M.; Durand, T.; Le Guennec, J.Y.; Lee, J.C. Physiological role of reactive oxygen species as promoters of natural defenses. FASEB J. 2017, 31, 3729–3745. [Google Scholar] [CrossRef] [Green Version]
  69. Costa, J.D.S.; Ramos, R.D.S.; Costa, K.; Brasil, D.; Silva, C.; Ferreira, E.F.B.; Borges, R.D.S.; Campos, J.M.; Macedo, W.; Santos, C. An In Silico Study of the Antioxidant Ability for Two Caffeine Analogs Using Molecular Docking and Quantum Chemical Methods. Molecules 2018, 23, 2801. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Al-Hatamleh, M.A.I.; Ear, E.N.; Boer, J.C.; Ferji, K.; Six, J.L.; Chen, X.; Elkord, E.; Plebanski, M.; Mohamud, R. Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment. Cells 2019, 9, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Al-Hatamleh, M.; Tengku, M.; Alshajrawi, O.; Ilyas, M.; Rao, S.; Majid, L.; Zubaidi, A.; Nordin, S.; Atif, A. Obesity Leads to Elevated Level of Circulating Cell-Free DNA. Curr. Trends Biomed. Eng. Biosci. 2018, 16, 102–105. [Google Scholar] [CrossRef]
  72. Pi-Sunyer, X. The medical risks of obesity. Postgrad. Med. 2009, 121, 21–33. [Google Scholar] [CrossRef]
  73. Abdul Rahman, H.; Saari, N.; Abas, F.; Ismail, A.; Mumtaz, M.W.; Abdul Hamid, A. Anti-obesity and antioxidant activities of selected medicinal plants and phytochemical profiling of bioactive compounds. Int. J. Food Prop. 2017, 20, 2616–2629. [Google Scholar] [CrossRef]
  74. Al-Hatamleh, M.A.; Ahmad, S.; Boer, J.C.; Lim, J.; Chen, X.; Plebanski, M.; Mohamud, R. A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy. J. Oncol. 2019, 2019, 6313242. [Google Scholar] [CrossRef]
  75. Grivennikov, S.I.; Greten, F.R.; Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 883–899. [Google Scholar] [CrossRef] [Green Version]
  76. Waheed, M.; Hussain, M.B.; Javed, A.; Mushtaq, Z.; Hassan, S.; Shariati, M.A.; Khan, M.U.; Majeed, M.; Nigam, M.; Mishra, A.P.; et al. Honey and cancer: A mechanistic review. Clin. Nutr. 2019, 38, 2499–2503. [Google Scholar] [CrossRef]
  77. Al-Hatamleh, M.A.I.; Hussin, T.; Taib, W.R.W.; Ismail, I. The Brain-Derived Neurotrophic Factor (BDNF) gene Val66Met (rs6265) polymorphism and stress among preclinical medical students in Malaysia. J. Taibah Univ. Med. Sci. 2019, 14, 431–438. [Google Scholar] [CrossRef]
  78. Schorge, S.; van de Leemput, J.; Singleton, A.; Houlden, H.; Hardy, J. Human ataxias: A genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling. Trends Neurosci. 2010, 33, 211–219. [Google Scholar] [CrossRef] [Green Version]
  79. Ismail, M.M.; Ismail, W.I.W. Development of stingless beekeeping projects in Malaysia. Proceedings of E3S Web of Conferences, Polanica-Zdrój, Poland, 16–18 April 2018; p. 00028. [Google Scholar]
  80. Mustafa, M.Z.; Yaacob, N.S.; Sulaiman, S.A. Reinventing the Honey Industry: Opportunities of the Stingless Bee. Malays. J. Med. Sci. 2018, 25, 1–5. [Google Scholar] [CrossRef] [PubMed]
  81. Ismail, M.M. Honey Marketing in Malaysia. In Agricultural Marketing Issues of Selected Commodities; Universiti Putra Malaysia Press: Serdang, Selangor, Malaysia, 2012; pp. 136–152. [Google Scholar]
  82. Omar, S.; Enchang, F.K.; Nazri, M.U.I.A.; Ismail, M.M.; Ismail, W.I.W. Physicochemical profiles of honey harvested from four major species of stingless bee (Kelulut) in North East Peninsular of Malaysia. Malays. Appl. Biol. 2019, 48, 111–116. [Google Scholar]
  83. Martinotti, S.; Ranzato, E. Propolis: A new frontier for wound healing? Burns Trauma 2015, 3, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Fernandes, J.R.A.; Leomil, L.; Fernandes, A.A.H.; Sforcin, J.M. The antibacterial activity of propolis produced by Apis mellifera L. and Brazilian stingless bees. J. Venom. Anim. Toxins 2001, 7, 173–182. [Google Scholar] [CrossRef]
  85. da Cunha, M.G.; de Cassia Orlandi Sardi, J.; Freires, I.A.; Franchin, M.; Rosalen, P.L. Antimicrobial, anti-adherence and antibiofilm activity against Staphylococcus aureus of a 4-phenyl coumarin derivative isolated from Brazilian geopropolis. Microb. Pathog. 2020, 139, 103855. [Google Scholar] [CrossRef]
  86. Rubinho, M.P.; de Carvalho, P.L.N.; Reis, A.; Reis, E.; de Alencar, S.M.; Ruiz, A.; de Carvalho, J.E.; Ikegaki, M. A comprehensive characterization of polyphenols by LC-ESI-QTOF-MS from Melipona quadrifasciata anthidioides geopropolis and their antibacterial, antioxidant and antiproliferative effects. Nat. Prod. Res. 2019, 1–6. [Google Scholar] [CrossRef]
  87. Pujirahayu, N.; Bhattacharjya, D.K.; Suzuki, T.; Katayama, T. alpha-Glucosidase Inhibitory Activity of Cycloartane-Type Triterpenes Isolated from Indonesian Stingless Bee Propolis and Their Structure-Activity Relationship. Pharmaceuticals 2019, 12, 102. [Google Scholar] [CrossRef] [Green Version]
  88. Abdullah, N.A.; Ja’afar, F.; Yasin, H.M.; Taha, H.; Petalcorin, M.I.R.; Mamit, M.H.; Kusrini, E.; Usman, A. Physicochemical analyses, antioxidant, antibacterial, and toxicity of propolis particles produced by stingless bee Heterotrigona itama found in Brunei Darussalam. Heliyon 2019, 5, e02476. [Google Scholar] [CrossRef] [Green Version]
  89. Iqbal, M.; Fan, T.P.; Watson, D.; Alenezi, S.; Saleh, K.; Sahlan, M. Preliminary studies: The potential anti-angiogenic activities of two Sulawesi Island (Indonesia) propolis and their chemical characterization. Heliyon 2019, 5, e01978. [Google Scholar] [CrossRef] [Green Version]
  90. Cisilotto, J.; Sandjo, L.P.; Faqueti, L.G.; Fernandes, H.; Joppi, D.; Biavatti, M.W.; Creczynski-Pasa, T.B. Cytotoxicity mechanisms in melanoma cells and UPLC-QTOF/MS(2) chemical characterization of two Brazilian stingless bee propolis: Uncommon presence of piperidinic alkaloids. J. Pharm. Biomed. Anal. 2018, 149, 502–511. [Google Scholar] [CrossRef]
  91. Brodkiewicz, Y.; Marcinkevicius, K.; Reynoso, M.; Salomon, V.; Maldonado, L.; Vera, N. Studies of the biological and therapeutic effects of Argentine stingless bee propolis. J. Drug Deliv. Ther. 2018, 8, 382–392. [Google Scholar] [CrossRef]
  92. Kustiawan, P.M.; Lirdprapamongkol, K.; Palaga, T.; Puthong, S.; Phuwapraisirisan, P.; Svasti, J.; Chanchao, C. Molecular mechanism of cardol, isolated from Trigona incisa stingless bee propolis, induced apoptosis in the SW620 human colorectal cancer cell line. BMC Pharmacol. Toxicol. 2017, 18, 32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Sabir, A.; Sumidarti, A. Interleukin-6 expression on inflamed rat dental pulp tissue after capped with Trigona sp. propolis from south Sulawesi, Indonesia. Saudi J. Biol. Sci. 2017, 24, 1034–1037. [Google Scholar] [CrossRef] [PubMed]
  94. Utispan, K.; Chitkul, B.; Koontongkaew, S. Cytotoxic Activity of Propolis Extracts from the Stingless Bee Trigona Sirindhornae Against Primary and Metastatic Head and Neck Cancer Cell Lines. Asian Pac. J. Cancer Prev. 2017, 18, 1051–1055. [Google Scholar] [CrossRef]
  95. Nguyen, H.X.; Nguyen, M.T.T.; Nguyen, N.T.; Awale, S. Chemical Constituents of Propolis from Vietnamese Trigona minor and Their Antiausterity Activity against the PANC-1 Human Pancreatic Cancer Cell Line. J. Nat. Prod. 2017, 80, 2345–2352. [Google Scholar] [CrossRef] [PubMed]
  96. Santos, H.F.D.; Campos, J.F.; Santos, C.M.D.; Balestieri, J.B.P.; Silva, D.B.; Carollo, C.A.; de Picoli Souza, K.; Estevinho, L.M.; Dos Santos, E.L. Chemical Profile and Antioxidant, Anti-Inflammatory, Antimutagenic and Antimicrobial Activities of Geopropolis from the Stingless Bee Melipona orbignyi. Int. J. Mol. Sci. 2017, 18, 953. [Google Scholar] [CrossRef] [PubMed]
  97. Utispan, K.; Chitkul, B.; Monthanapisut, P.; Meesuk, L.; Pugdee, K.; Koontongkaew, S. Propolis Extracted from the Stingless Bee Trigona sirindhornae Inhibited S. mutans Activity In Vitro. Oral Health Prev. Dent. 2017, 15, 279–284. [Google Scholar] [CrossRef] [PubMed]
  98. Massaro, C.F.; Smyth, T.J.; Smyth, W.F.; Heard, T.; Leonhardt, S.D.; Katouli, M.; Wallace, H.M.; Brooks, P. Phloroglucinols from anti-microbial deposit-resins of Australian stingless bees (Tetragonula carbonaria). Phytother. Res. 2015, 29, 48–58. [Google Scholar] [CrossRef]
  99. Campos, J.F.; Dos Santos, U.P.; da Rocha Pdos, S.; Damiao, M.J.; Balestieri, J.B.; Cardoso, C.A.; Paredes-Gamero, E.J.; Estevinho, L.M.; de Picoli Souza, K.; Dos Santos, E.L. Antimicrobial, Antioxidant, Anti-Inflammatory, and Cytotoxic Activities of Propolis from the Stingless Bee Tetragonisca fiebrigi (Jatai). Evid. Based Complement. Alternat. Med. 2015, 2015, 296186. [Google Scholar] [CrossRef] [Green Version]
  100. Sanpa, S.; Popova, M.; Bankova, V.; Tunkasiri, T.; Eitssayeam, S.; Chantawannakul, P. Antibacterial Compounds from Propolis of Tetragonula laeviceps and Tetrigona melanoleuca (Hymenoptera: Apidae) from Thailand. PLoS ONE 2015, 10, e0126886. [Google Scholar] [CrossRef]
  101. Kothai, S.; Jayanthi, B. Anti cancer activity of silver nano particles bio-synthesized using stingless bee propolis (Tetragonula iridipennis) of Tamilnadu. Asian J. Biomed. Pharm. Sci. 2015, 5, 30. [Google Scholar] [CrossRef]
  102. Kustiawan, P.M.; Phuwapraisirisan, P.; Puthong, S.; Palaga, T.; Arung, E.T.; Chanchao, C. Propolis from the Stingless Bee Trigona incisa from East Kalimantan, Indonesia, Induces In Vitro Cytotoxicity and Apoptosis in Cancer Cell lines. Asian Pac. J. Cancer Prev. 2015, 16, 6581–6589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Dutra, R.P.; Abreu, B.V.; Cunha, M.S.; Batista, M.C.; Torres, L.M.; Nascimento, F.R.; Ribeiro, M.N.; Guerra, R.N. Phenolic acids, hydrolyzable tannins, and antioxidant activity of geopropolis from the stingless bee Melipona fasciculata Smith. J. Agric. Food Chem. 2014, 62, 2549–2557. [Google Scholar] [CrossRef]
  104. Massaro, C.F.; Katouli, M.; Grkovic, T.; Vu, H.; Quinn, R.J.; Heard, T.A.; Carvalho, C.; Manley-Harris, M.; Wallace, H.M.; Brooks, P. Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae). Fitoterapia 2014, 95, 247–257. [Google Scholar] [CrossRef]
  105. Campos, J.F.; dos Santos, U.P.; Macorini, L.F.; de Melo, A.M.; Balestieri, J.B.; Paredes-Gamero, E.J.; Cardoso, C.A.; de Picoli Souza, K.; dos Santos, E.L. Antimicrobial, antioxidant and cytotoxic activities of propolis from Melipona orbignyi (Hymenoptera, Apidae). Food Chem. Toxicol. 2014, 65, 374–380. [Google Scholar] [CrossRef] [PubMed]
  106. de Farias, J.H.; Reis, A.S.; Araujo, M.A.; Araujo, M.J.; Assuncao, A.K.; de Farias, J.C.; Fialho, E.M.; Silva, L.A.; Costa, G.C.; Guerra, R.N.; et al. Effects of stingless bee propolis on experimental asthma. Evid. Based Complement. Altern. Med. 2014, 2014, 951478. [Google Scholar] [CrossRef] [Green Version]
  107. da Cunha, M.G.; Franchin, M.; de Carvalho Galvao, L.C.; de Ruiz, A.L.; de Carvalho, J.E.; Ikegaki, M.; de Alencar, S.M.; Koo, H.; Rosalen, P.L. Antimicrobial and antiproliferative activities of stingless bee Melipona scutellaris geopropolis. BMC Complement. Altern. Med. 2013, 13, 23. [Google Scholar] [CrossRef] [Green Version]
  108. Choudhari, M.K.; Haghniaz, R.; Rajwade, J.M.; Paknikar, K.M. Anticancer activity of Indian stingless bee propolis: An in vitro study. Evid. Based Complement. Altern. Med. 2013, 2013, 928280. [Google Scholar] [CrossRef] [Green Version]
  109. Cinegaglia, N.C.; Bersano, P.R.; Araujo, M.J.; Bufalo, M.C.; Sforcin, J.M. Anticancer effects of geopropolis produced by stingless bees on canine osteosarcoma cells in vitro. Evid. Based Complement. Altern. Med. 2013, 2013, 737386. [Google Scholar] [CrossRef] [Green Version]
  110. Massaro, F.C.; Brooks, P.R.; Wallace, H.M.; Nsengiyumva, V.; Narokai, L.; Russell, F.D. Effect of Australian propolis from stingless bees (Tetragonula carbonaria) on pre-contracted human and porcine isolated arteries. PLoS ONE 2013, 8, e81297. [Google Scholar] [CrossRef] [Green Version]
  111. Franchin, M.; da Cunha, M.G.; Denny, C.; Napimoga, M.H.; Cunha, T.M.; Koo, H.; de Alencar, S.M.; Ikegaki, M.; Rosalen, P.L. Geopropolis from Melipona scutellaris decreases the mechanical inflammatory hypernociception by inhibiting the production of IL-1beta and TNF-alpha. J. Ethnopharmacol. 2012, 143, 709–715. [Google Scholar] [CrossRef] [PubMed]
  112. Choudhari, M.K.; Punekar, S.A.; Ranade, R.V.; Paknikar, K.M. Antimicrobial activity of stingless bee (Trigona sp.) propolis used in the folk medicine of Western Maharashtra, India. J. Ethnopharmacol. 2012, 141, 363–367. [Google Scholar] [CrossRef] [PubMed]
  113. Umthong, S.; Phuwapraisirisan, P.; Puthong, S.; Chanchao, C. In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines. BMC Complement. Altern. Med. 2011, 11, 37. [Google Scholar] [CrossRef] [Green Version]
  114. Liberio, S.A.; Pereira, A.L.; Dutra, R.P.; Reis, A.S.; Araujo, M.J.; Mattar, N.S.; Silva, L.A.; Ribeiro, M.N.; Nascimento, F.R.; Guerra, R.N.; et al. Antimicrobial activity against oral pathogens and immunomodulatory effects and toxicity of geopropolis produced by the stingless bee Melipona fasciculata Smith. BMC Complement. Altern. Med. 2011, 11, 108. [Google Scholar] [CrossRef] [Green Version]
  115. Umthong, S.; Puthong, S.; Chanchao, C. Trigona laeviceps propolis from Thailand: Antimicrobial, antiproliferative and cytotoxic activities. Am. J. Chin. Med. 2009, 37, 855–865. [Google Scholar] [CrossRef] [PubMed]
  116. Farnesi, A.P.; Aquino-Ferreira, R.; De Jong, D.; Bastos, J.K.; Soares, A.E. Effects of stingless bee and honey bee propolis on four species of bacteria. Genet. Mol. Res. 2009, 8, 635–640. [Google Scholar] [CrossRef]
  117. Manrique, A.J.; Santana, W.C. Flavonoids, antibacterial and antioxidant activities of propolis of stingless bees, Melipona quadrifasciata, Melipona compressipes, Tetragonisca angustula, and Nannotrigona sp. from Brazil and Venezuela. Zootec. Trop. 2008, 26, 157–166. [Google Scholar]
  118. Velikova, M.; Bankova, V.; Marcucci, M.C.; Tsvetkova, I.; Kujumgiev, A. Chemical composition and biological activity of propolis from Brazilian meliponinae. Z. Nat. C J. Biosci. 2000, 55, 785–789. [Google Scholar] [CrossRef]
  119. de Souza, S.A.; da Silva, T.M.G.; da Silva, E.M.S.; Camara, C.A.; Silva, T.M.S. Characterisation of phenolic compounds by UPLC-QTOF-MS/MS of geopropolis from the stingless bee Melipona subnitida (jandaira). Phytochem. Anal. 2018, 29, 549–558. [Google Scholar] [CrossRef]
  120. Pino, J.A.; Marbot, R.; Delgado, A.; Zumárraga, C.; Sauri, E. Volatile Constituents of Propolis from Honey Bees and Stingless Bees from Yucatán. J. Essent. Oil Res. 2006, 18, 53–56. [Google Scholar] [CrossRef]
  121. Utegenova, G.A.; Pallister, K.B.; Kushnarenko, S.V.; Ozek, G.; Ozek, T.; Abidkulova, K.T.; Kirpotina, L.N.; Schepetkin, I.A.; Quinn, M.T.; Voyich, J.M. Chemical Composition and Antibacterial Activity of Essential Oils from Ferula L. Species against Methicillin-Resistant Staphylococcus aureus. Molecules 2018, 23, 1679. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  122. Dahham, S.S.; Tabana, Y.M.; Iqbal, M.A.; Ahamed, M.B.; Ezzat, M.O.; Majid, A.S.; Majid, A.M. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene beta-Caryophyllene from the Essential Oil of Aquilaria crassna. Molecules 2015, 20, 11808–11829. [Google Scholar] [CrossRef] [PubMed]
  123. Crane, E. Bee Products. In Encyclopedia of Insects; Resh, V., Cardé, R., Eds.; Elsevier: Cambridge, MA, USA, 2009; pp. 71–75. [Google Scholar]
  124. Massaro, F.C.; Brooks, P.R.; Wallace, H.M.; Russell, F.D. Cerumen of Australian stingless bees (Tetragonula carbonaria): Gas chromatography-mass spectrometry fingerprints and potential anti-inflammatory properties. Naturwissenschaften 2011, 98, 329–337. [Google Scholar] [CrossRef] [PubMed]
  125. Paludo, C.R.; Pishchany, G.; Andrade-Dominguez, A.; Silva-Junior, E.A.; Menezes, C.; Nascimento, F.S.; Currie, C.R.; Kolter, R.; Clardy, J.; Pupo, M.T. Microbial community modulates growth of symbiotic fungus required for stingless bee metamorphosis. PLoS ONE 2019, 14, e0219696. [Google Scholar] [CrossRef]
  126. Lopes, A.J.O.; Vasconcelos, C.C.; Garcia, J.B.S.; Doria Pinheiro, M.S.; Pereira, F.A.N.; Camelo, D.S.; Morais, S.V.; Freitas, J.R.B.; Rocha, C.Q.D.; de Sousa Ribeiro, M.N.; et al. Anti-Inflammatory and Antioxidant Activity of Pollen Extract Collected by Scaptotrigona affinis postica: In silico, in vitro, and in vivo Studies. Antioxidants 2020, 9, 103. [Google Scholar] [CrossRef] [Green Version]
  127. Belina-Aldemita, M.D.; Schreiner, M.; D’Amico, S. Characterization of phenolic compounds and antioxidative potential of pot-pollen produced by stingless bees (Tetragonula biroi Friese) from the Philippines. J. Food Biochem. 2020, 44, e13102. [Google Scholar] [CrossRef]
  128. Lopes, A.J.O.; Vasconcelos, C.C.; Pereira, F.A.N.; Silva, R.H.M.; Queiroz, P.; Fernandes, C.V.; Garcia, J.B.S.; Ramos, R.M.; Rocha, C.Q.D.; Lima, S.; et al. Anti-Inflammatory and Antinociceptive Activity of Pollen Extract Collected by Stingless Bee Melipona fasciculata. Int. J. Mol. Sci. 2019, 20, 4512. [Google Scholar] [CrossRef] [Green Version]
  129. Omar, W.A.W.; Azhar, N.A.; Fadzilah, N.H.; Kamal, N.N.S.N.M. Bee pollen extract of Malaysian stingless bee enhances the effect of cisplatin on breast cancer cell lines. Asian Pac. J. Trop. Biomed. 2016, 6, 265–269. [Google Scholar] [CrossRef] [Green Version]
  130. Barbara, M.S.; Machado, C.S.; Sodre Gda, S.; Dias, L.G.; Estevinho, L.M.; de Carvalho, C.A. Microbiological Assessment, Nutritional Characterization and Phenolic Compounds of Bee Pollen from Mellipona mandacaia Smith, 1983. Molecules 2015, 20, 12525–12544. [Google Scholar] [CrossRef] [Green Version]
  131. Tomás, A.; Falcão, S.I.; Russo-Almeida, P.; Vilas-Boas, M. Potentialities of beebread as a food supplement and source of nutraceuticals: Botanical origin, nutritional composition and antioxidant activity. J. Apic. Res. 2017, 56, 219–230. [Google Scholar] [CrossRef]
  132. Usman, A.N.; Syam, Y.; Natzir, R.; Rahardjo, S.P.; Hatta, M.; Dwiyanti, R.; Widaningsih, Y. The effect of giving trigona honey and honey propolis trigona to the mRNA Foxp3 expression in mice Balb/c strain induced by Salmonella typhi. Am. J. Biomed. Res. 2016, 4, 42–45. [Google Scholar] [CrossRef]
  133. Ngalimat, M.S.; Raja Abd Rahman, R.N.Z.; Yusof, M.T.; Syahir, A.; Sabri, S. Characterisation of bacteria isolated from the stingless bee, Heterotrigona itama, honey, bee bread and propolis. PeerJ 2019, 7, e7478. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  134. Cambronero-Heinrichs, J.C.; Matarrita-Carranza, B.; Murillo-Cruz, C.; Araya-Valverde, E.; Chavarria, M.; Pinto-Tomas, A.A. Phylogenetic analyses of antibiotic-producing Streptomyces sp. isolates obtained from the stingless-bee Tetragonisca angustula (Apidae: Meliponini). Microbiology 2019, 165, 292–301. [Google Scholar] [CrossRef]
  135. Campos, F.M.; Couto, J.A.; Figueiredo, A.R.; Toth, I.V.; Rangel, A.O.; Hogg, T.A. Cell membrane damage induced by phenolic acids on wine lactic acid bacteria. Int. J. Food Microbiol. 2009, 135, 144–151. [Google Scholar] [CrossRef] [PubMed]
  136. Lechner, D.; Gibbons, S.; Bucar, F. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J. Antimicrob. Chemother. 2008, 62, 345–348. [Google Scholar] [CrossRef] [Green Version]
  137. Rodrigues, L.; Ainsa, J.; Amaral, L.; Viveiros, M. Inhibition of drug efflux in mycobacteria with phenothiazines and other putative efflux inhibitors. Recent Pat. Anti-Infect. Drug Discov. 2011, 6, 118–127. [Google Scholar] [CrossRef]
  138. Jeong, K.W.; Lee, J.Y.; Kang, D.I.; Lee, J.U.; Shin, S.Y.; Kim, Y. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis. J. Nat. Prod. 2009, 72, 719–724. [Google Scholar] [CrossRef]
  139. Brown, A.R.; Ettefagh, K.A.; Todd, D.; Cole, P.S.; Egan, J.M.; Foil, D.H.; Graf, T.N.; Schindler, B.D.; Kaatz, G.W.; Cech, N.B. A mass spectrometry-based assay for improved quantitative measurements of efflux pump inhibition. PLoS ONE 2015, 10, e0124814. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  140. Wu, D.; Kong, Y.; Han, C.; Chen, J.; Hu, L.; Jiang, H.; Shen, X. D-Alanine:D-alanine ligase as a new target for the flavonoids quercetin and apigenin. Int. J. Antimicrob. Agents 2008, 32, 421–426. [Google Scholar] [CrossRef]
  141. Shao, J.; Zhang, M.; Wang, T.; Li, Y.; Wang, C. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans. Pharm. Biol. 2016, 54, 984–992. [Google Scholar] [CrossRef] [Green Version]
  142. Randhawa, H.K.; Hundal, K.K.; Ahirrao, P.N.; Jachak, S.M.; Nandanwar, H.S. Efflux pump inhibitory activity of flavonoids isolated from Alpinia calcarata against methicillin-resistant Staphylococcus aureus. Biologia 2016, 71, 484–493. [Google Scholar] [CrossRef]
  143. Nimse, S.B.; Pal, D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015, 5, 27986–28006. [Google Scholar] [CrossRef] [Green Version]
  144. Teles Fujishima, M.A.; Silva, N.; Ramos, R.D.S.; Batista Ferreira, E.F.; Santos, K.; Silva, C.; Silva, J.O.D.; Campos Rosa, J.M.; Santos, C. An Antioxidant Potential, Quantum-Chemical and Molecular Docking Study of the Major Chemical Constituents Present in the Leaves of Curatella americana Linn. Pharmaceuticals 2018, 11, 72. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Kek, S.P.; Chin, N.L.; Tan, S.W.; Yusof, Y.A.; Chua, L.S. Classification of honey from its bee origin via chemical profiles and mineral content. Food Anal. Methods 2017, 10, 19–30. [Google Scholar] [CrossRef]
  146. Razali, M.; Zainal, Z.; Maulidiani, M.; Shaari, K.; Zamri, Z.; Mohd Idrus, M.; Khatib, A.; Abas, F.; Ling, Y.; Rui, L. Classification of Raw Stingless Bee Honeys by Bee Species Origins Using the NMR-and LC-MS-Based Metabolomics Approach. Molecules 2018, 23, 2160. [Google Scholar] [CrossRef] [Green Version]
  147. Zheng, H.; Steele, M.I.; Leonard, S.P.; Motta, E.V.S.; Moran, N.A. Honey bees as models for gut microbiota research. Lab. Anim. 2018, 47, 317–325. [Google Scholar] [CrossRef]
  148. Mohamud, R.; Xiang, S.D.; Selomulya, C.; Rolland, J.M.; O’Hehir, R.E.; Hardy, C.L.; Plebanski, M. The effects of engineered nanoparticles on pulmonary immune homeostasis. Drug Metab. Rev. 2014, 46, 176–190. [Google Scholar] [CrossRef] [PubMed]
  149. Shah, M.; Fawcett, D.; Sharma, S.; Tripathy, S.K.; Poinern, G.E.J. Green Synthesis of Metallic Nanoparticles via Biological Entities. Materials 2015, 8, 7278–7308. [Google Scholar] [CrossRef] [Green Version]
  150. Kalpana, V.N.; Devi Rajeswari, V. A Review on Green Synthesis, Biomedical Applications, and Toxicity Studies of ZnO NPs. Bioinorg. Chem. Appl. 2018, 2018, 3569758. [Google Scholar] [CrossRef]
  151. Balasooriya, E.R.; Jayasinghe, C.D.; Jayawardena, U.A.; Ruwanthika, R.W.D.; Mendis de Silva, R.; Udagama, P.V. Honey mediated green synthesis of nanoparticles: New era of safe nanotechnology. J. Nanomater. 2017, 2017, 5919836. [Google Scholar] [CrossRef]
  152. Oyewumi, M.O.; Kumar, A.; Cui, Z. Nano-microparticles as immune adjuvants: Correlating particle sizes and the resultant immune responses. Expert Rev. Vaccines 2010, 9, 1095–1107. [Google Scholar] [CrossRef] [Green Version]
  153. Ahmad, S.; Azid, N.A.; Boer, J.C.; Lim, J.; Chen, X.; Plebanski, M.; Mohamud, R. The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review. Front. Immunol. 2018, 9, 2572. [Google Scholar] [CrossRef]
  154. Engel, P.; Martinson, V.G.; Moran, N.A. Functional diversity within the simple gut microbiota of the honey bee. Proc. Natl. Acad. Sci. USA 2012, 109, 11002–11007. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  155. Lee, F.J.; Rusch, D.B.; Stewart, F.J.; Mattila, H.R.; Newton, I.L. Saccharide breakdown and fermentation by the honey bee gut microbiome. Environ. Microbiol. 2015, 17, 796–815. [Google Scholar] [CrossRef]
  156. Martinson, V.G.; Danforth, B.N.; Minckley, R.L.; Rueppell, O.; Tingek, S.; Moran, N.A. A simple and distinctive microbiota associated with honey bees and bumble bees. Mol. Ecol. 2011, 20, 619–628. [Google Scholar] [CrossRef]
  157. Kwong, W.K.; Moran, N.A. Cultivation and characterization of the gut symbionts of honey bees and bumble bees: Description of Snodgrassella alvi gen. nov., sp. nov., a member of the family Neisseriaceae of the Betaproteobacteria, and Gilliamella apicola gen. nov., sp. nov., a member of Orbaceae fam. nov., Orbales ord. nov., a sister taxon to the order ‘Enterobacteriales’ of the Gammaproteobacteria. Int. J. Syst. Evol. Microbiol. 2013, 63, 2008–2018. [Google Scholar] [CrossRef]
  158. Engel, P.; Kwong, W.K.; Moran, N.A. Frischella perrara gen. nov., sp. nov., a gammaproteobacterium isolated from the gut of the honeybee, Apis mellifera. Int. J. Syst. Evol. Microbiol. 2013, 63, 3646–3651. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Principal characteristics of stingless bees that differentiate them from honeybees [7].
Figure 1. Principal characteristics of stingless bees that differentiate them from honeybees [7].
Biomolecules 10 00923 g001
Figure 2. Hive box containing colony of stingless bees (Heterotrigona itama). A, cerumen; B, empty propolis pot; C, honey; D, bee pollen; E, fermented pollen (beebread).
Figure 2. Hive box containing colony of stingless bees (Heterotrigona itama). A, cerumen; B, empty propolis pot; C, honey; D, bee pollen; E, fermented pollen (beebread).
Biomolecules 10 00923 g002
Figure 3. A comparison between the annual publications on both stingless bees and honey bees in the recent 10 years. Applied on PubMed database on May 9, 2020, by using search terms: (Honeybee; Honey bee; Apis; European bee; Western bee) and (Stingless bee; Melipona; Trigona).
Figure 3. A comparison between the annual publications on both stingless bees and honey bees in the recent 10 years. Applied on PubMed database on May 9, 2020, by using search terms: (Honeybee; Honey bee; Apis; European bee; Western bee) and (Stingless bee; Melipona; Trigona).
Biomolecules 10 00923 g003
Figure 4. The principal of oxidative damage and the role of antioxidants in scavenging free radicals. (A) The free radicals generated from endogenous sources, at limited concentrations, are considered important for regulation of cell maturation, in addition to their role in immune defense. Excessive concentrations of these unstable molecules can result from illness conditions and exogenous sources, and thus lead to oxidative damage (imbalance between free radical and antioxidant concentrations). This status results in cell injury/death based on the extremely high reactivity of free radicals with vital cellular molecules including lipids, amino acids, proteins and DNA. (B) Antioxidants are necessary to stop the oxidative damage by neutralizing free radicals. They own this unique role due to their capability to give an electron to free radicals that have unpaired electrons to make them stable and unharmful. Phenolic compounds present in stingless bee honey products have antioxidant properties. ROS, reactive oxygen species; RNS, reactive nitrogen species [55,56].
Figure 4. The principal of oxidative damage and the role of antioxidants in scavenging free radicals. (A) The free radicals generated from endogenous sources, at limited concentrations, are considered important for regulation of cell maturation, in addition to their role in immune defense. Excessive concentrations of these unstable molecules can result from illness conditions and exogenous sources, and thus lead to oxidative damage (imbalance between free radical and antioxidant concentrations). This status results in cell injury/death based on the extremely high reactivity of free radicals with vital cellular molecules including lipids, amino acids, proteins and DNA. (B) Antioxidants are necessary to stop the oxidative damage by neutralizing free radicals. They own this unique role due to their capability to give an electron to free radicals that have unpaired electrons to make them stable and unharmful. Phenolic compounds present in stingless bee honey products have antioxidant properties. ROS, reactive oxygen species; RNS, reactive nitrogen species [55,56].
Biomolecules 10 00923 g004
Figure 5. Phenolic acids have been reported in different types of SBH.
Figure 5. Phenolic acids have been reported in different types of SBH.
Biomolecules 10 00923 g005
Figure 6. Flavonoids have been reported in different types of SBH.
Figure 6. Flavonoids have been reported in different types of SBH.
Biomolecules 10 00923 g006aBiomolecules 10 00923 g006b
Figure 7. Other phenolic compounds have been reported in different types of SBH.
Figure 7. Other phenolic compounds have been reported in different types of SBH.
Biomolecules 10 00923 g007
Figure 8. Potential mechanisms of actions for antioxidant phenolic compounds as immunomodulatory and anti-inflammatory agents [66]. These mechanisms work mainly through inhibition of two key signaling pathways; the mitogen-activated protein kinases (MAPK) and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and arachidonic acid signaling pathways. This inhibition results in complicated cellular mechanisms finished with suppression of pro-inflammatory gens, and thus block the expression of pro-inflammatory cytokines (e.g., tumor necrosis factor-alpha (TNF) and interleukin (IL)-6). In addition, the phenolic compounds also reduce the release of arachidonic acid which results upon the oxidation of membrane phospholipids, and thus reduce also its metabolites (leukotrienes and prostaglandins) that considered as important inflammatory mediators.
Figure 8. Potential mechanisms of actions for antioxidant phenolic compounds as immunomodulatory and anti-inflammatory agents [66]. These mechanisms work mainly through inhibition of two key signaling pathways; the mitogen-activated protein kinases (MAPK) and the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and arachidonic acid signaling pathways. This inhibition results in complicated cellular mechanisms finished with suppression of pro-inflammatory gens, and thus block the expression of pro-inflammatory cytokines (e.g., tumor necrosis factor-alpha (TNF) and interleukin (IL)-6). In addition, the phenolic compounds also reduce the release of arachidonic acid which results upon the oxidation of membrane phospholipids, and thus reduce also its metabolites (leukotrienes and prostaglandins) that considered as important inflammatory mediators.
Biomolecules 10 00923 g008
Figure 9. The antimicrobial activities of SBH that have been examined to date.
Figure 9. The antimicrobial activities of SBH that have been examined to date.
Biomolecules 10 00923 g009
Figure 10. The major phenolic compounds that have been reported in SBPs [17,51,96,103].
Figure 10. The major phenolic compounds that have been reported in SBPs [17,51,96,103].
Biomolecules 10 00923 g010
Figure 11. The major phenolic compounds that have been reported in stingless bee pollen [126,127,130].
Figure 11. The major phenolic compounds that have been reported in stingless bee pollen [126,127,130].
Biomolecules 10 00923 g011
Figure 12. The proposed radical scavenging activity of ascorbic acid (adapted from Nimse and Pal, 2015 [143]—published by The Royal Society of Chemistry).
Figure 12. The proposed radical scavenging activity of ascorbic acid (adapted from Nimse and Pal, 2015 [143]—published by The Royal Society of Chemistry).
Biomolecules 10 00923 g012
Table 1. List of studies on the potential medicinal properties of stingless bee honey (SBH).
Table 1. List of studies on the potential medicinal properties of stingless bee honey (SBH).
Study IDCountry of OriginSpeciesReported Properties
Arshad 2020 [24]MalaysiaTrigonaImprove memory
Reduces anxiety
Biluca 2020 [25]BrazilMelipona marginata
Tetragona clavipes
Scaptotrigona bicunctata
Melipona quadriasciata
Tetragonisca angustula
Trigona hypogea
Antioxidant
Anti-inflammatory
Mustafa 2019 [26]MalaysiaHeterotrigona itamaImproves memory and learning
Abdul Malik 2019 [27]MalaysiaHeterotrigona itamaAntiaging
Hazirah 2019 [28]MalaysiaTrigonaAntioxidant
Al Kafaween 2019 [29]MalaysiaTrigonaAntimicrobial
Avila 2019 [30]BrazilMelipona bicolor
Melipona quadrifasciata
Melipona marginata
Scaptotrigona bipuncata
Antimicrobial
Antioxidant
Selvaraju 2019 [31]MalaysiaHeterotrigona itama
Geniotrigona thoracica
Antioxidant
Ranneh 2019 [32]MalaysiaTrigonaAnti-inflammatory
Antioxidant
Ahmad 2019 [33]MalaysiaHeterotrigona itamaAnticancer
Mohd Rafie 2018 [34]MalaysiaHeterotrigona itamaAnti-obesity
Mohamad 2018 [35]MalaysiaTrigona itamaAntiproliferative
Nordin 2018 [36]MalaysiaTrigona itama
Trigona thorasica
Improve wound healing
Ng 2017 [37]MalaysiaTrigonaAntibacterial
Aziz 2017 [38]MalaysiaGeniotrigona thoracicaAnti-obesity
Antidiabetic
Antioxidant
Budin 2017 [39]MalaysiaTrigonaAntioxidant
Improves fertility
Zamora 2017 [40]Costa RicaTetragonisca angustula
Melipona beecheii
Antimicrobial
Saiful Yazan 2016 [41]MalaysiaTrigonaAnticancer
Syam 2016 [42]IndonesiaTrigonaAnti-inflammatory
Massora 2014 [43]AustraliaTetragonula carbonariaAntimicrobial
Borsato 2014 [44]BrazilMelipona marginataAnti-inflammatory
Antioxidant
Ilechie 2012 [45]GhanaMeliponulaAntimicrobial
Anti-inflammatory
Boorn 2010 [46]AustraliaTrigona carbonariaAntimicrobial
Garedew 2004 [47]EthiopiaTrigonaAntimicrobial
Torres 2004 [48]ColombiaTetragonisca angustulaAntimicrobial
Patricia 2002 [49]VenezuelaMelipona favosaAnti-inflammatory
Table 2. List of studies on the potential medicinal properties of Stingless Bee Propolis (SBP).
Table 2. List of studies on the potential medicinal properties of Stingless Bee Propolis (SBP).
Study IDCountry of OriginSpeciesReported Properties
da Cunha 2020 [85]BrazilMelipona scutellarisAntimicrobial
Anti-adherence and Anti-biofilm
Rubinho 2019 [86]BrazilMelipona quadrifasciataAntioxidant
Antimicrobial
Pujirahayu 2019 [87]IndonesiaTetragonula sapiensAntioxidant
Abdullah 2019 [88]Brunei DarussalamHeterotrigona itamaAntioxidant
Antimicrobial
Iqbal 2019 [89]IndonesiaTrigonaAnticancer
Cisilotto 2018 [90]BrazilScaptotrigona bipunctata
Melipona quadrifasciata
Antioxidant
Brodkiewicz 2018 [91]ArgentinaTetragonisca fiebrigi
Scaptotrigona jujuyensis
Antioxidant
Antimicrobial Anti-inflammatory Anticancer
Kustiawan 2017 [92]ThailandTrigona incisaAnticancer
Sabir 2017 [93]IndonesiaTrigonaAnti-inflammatory
Bonamigo 2017 [51]BrazilScaptotrigona depilis
Melipona quadrifasciata anthidioides
Antioxidant
Anticancer
Utispan 2017 [94]ThailandTrigona sirindhornaeAnticancer
Nguyen 2017 [95]VietnamTrigona minorAnticancer
Santos 2017 [96]BrazilMelipona orbignyiAntioxidant
Antimicrobial
Utispan 2017 [97]ThailandTrigona sirindhornaeAntibacterial
Massaro 2015 [98]AustraliaTetragonula carbonariaAntibacterial
Campos 2015 [99]BrazilTetragonisca fiebrigiAntioxidant
Anti-inflammatory Antimicrobial
Anticancer
Sanpa 2015 [100]ThailandTetragonula laeviceps
Tetrigona melanoleuca
Antibacterial
Kothai 2015 [101]IndiaTetragonula iridipennisAnticancer
Kustiawan 2015 [102]ThailandTrigona incisaAnticancer
Dutra 2014 [103]BrazilMelipona fasciculataAntioxidant
Massaro 2014 [104]AustraliaTetragonula carbonariaAntibacterial
Campos 2014 [105]BrazilMelipona orbignyiAntioxidant
Anticancer
de Farias 2014 [106]BrazilScaptotrigona posticaAnti-inflammatory
da Cunha 2013 [107]BrazilMelipona scutellarisAntibacterial
Anticancer
Choudhari 2013 [108]IndiaTrigonaAnticancer Antioxidant
Cinegaglia 2013 [109]BrazilMelipona fasciculataAnticancer
Massaro 2013 [110]AustraliaTetragonula carbonariaManagement of cardiovascular disorders
Franchin 2012 [111]BrazilMelipona scutellarisAnti-inflammatory
Choudhari 2012 [112]IndiaTrigonaAntimicrobial
Umthong 2011 [113]ThailandTrigona laevicepsAnticancer
Liberio 2011 [114]BrazilMelipona fasciculataAntimicrobial
Umthong 2009 [115]ThailandTrigona laevicepsAntimicrobial Anticancer
Farnesi 2009 [116]BrazilMelipona quadrifasciata
Scaptotrigona
Antimicrobial
Manrique 2008 [117]Brazil and VenezuelaMelipona quadrifasciata Tetragonisca angustula Melipona compressipes
Nannotrigona
Antioxidant
Antimicrobial
Velikova 2000 [118]BrazilMeliponinaeAntimicrobial
Table 3. List of studies on the potential medicinal properties of cerumen and bee pollen from stingless bees.
Table 3. List of studies on the potential medicinal properties of cerumen and bee pollen from stingless bees.
Study IDCountry of OriginSpeciesReported Properties
Cerumen
Paludo 2019 [125]BrazilScaptotrigona depilisAntimicrobial
Nugitrangson 2015 [15]ThailandTetragonula laevicepsAnticancer
Massaro 2011 [124]AustraliaTetragonula carbonariaAnti-inflammatory
Bee Pollen
Lopes 2020 [126]BrazilScaptotrigona affinis posticaAntioxidant
Anti-inflammatory
Belina-Aldemita 2020 [127]PhilippineTetragonula biroi FrieseAntioxidant
Lopes 2019 [128]BrazilMelipona fasciculataAntioxidant
Anti-inflammatory
Omar 2016 [129]MalaysiaLepidotrigona terminataAntioxidant
Anticancer
Barbara 2015 [130]BrazilMelipona mandacaiaAntimicrobial
Table 4. List of studies on the potential medicinal properties of different stingless bee products.
Table 4. List of studies on the potential medicinal properties of different stingless bee products.
Study IDCountry of OriginSpeciesProductsReported Properties
Ngalimat 2019 [133]MalaysiaHeterotrigona itamaHoney
Propolis
Beebread
Antimicrobial
Cambronero-Heinrichs 2019 [134]Costa RicaTetragonisca angustulaAdult bees and different substrates of the hive (pollen and honey storage, garbage pellets and cerumen)Antimicrobial
Ismail 2018 [16]MalaysiaTrigonaHoney
Propolis
Beebread
Antioxidant Anticancer
Kustiawan 2014 [14]ThailandTrigona incise
Timia apicalis
Trigona fuscobalteata
Trigona fuscibasis
Propolis
Bee pollen
Honey
Anticancer
Usman 2016 [132]IndonesiaTrigonaHoney
Propolis
Anti-inflammatory
Table 5. List of effective antimicrobial phenolic compounds derived from plants extracts.
Table 5. List of effective antimicrobial phenolic compounds derived from plants extracts.
CompoundMechanisms of ActionTargetReferences
p-Coumaric
Caffeic acid
Ferulic acid
Damaging the cytoplasmic membrane by inducing ion leakages and proton influxOenococcus oeni and Lactobacillus hilgardii[135]
MyricetinInhibition of the intrinsic efflux pump systemMycobacterium smegmatis[136]
LuteolinInhibition of the intrinsic efflux pump systemMycobacteria spp.[136,137]
Naringenin
Eriodictyol
Taxifolin
Inhibition of β-Ketoacyl–Acyl Carrier Protein Synthase III (PfKASIII)Enterococcus faecalis[138]
QuercetinInhibition of the intrinsic efflux pump systemS. aureus[139]
Targeting d-Alanine:d-alanine LigaseHelicobacter pylori and E. coli[140]
ApigeninTargeting d-Alanine:d-alanine LigaseHelicobacter pylori and E. coli[140]
KaempferolInhibition of the intrinsic efflux pump systemC. albicans and S. aureus[141,142]

Share and Cite

MDPI and ACS Style

Al-Hatamleh, M.A.I.; Boer, J.C.; Wilson, K.L.; Plebanski, M.; Mohamud, R.; Mustafa, M.Z. Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions. Biomolecules 2020, 10, 923. https://doi.org/10.3390/biom10060923

AMA Style

Al-Hatamleh MAI, Boer JC, Wilson KL, Plebanski M, Mohamud R, Mustafa MZ. Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions. Biomolecules. 2020; 10(6):923. https://doi.org/10.3390/biom10060923

Chicago/Turabian Style

Al-Hatamleh, Mohammad A. I., Jennifer C. Boer, Kirsty L. Wilson, Magdalena Plebanski, Rohimah Mohamud, and Mohd Zulkifli Mustafa. 2020. "Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions" Biomolecules 10, no. 6: 923. https://doi.org/10.3390/biom10060923

APA Style

Al-Hatamleh, M. A. I., Boer, J. C., Wilson, K. L., Plebanski, M., Mohamud, R., & Mustafa, M. Z. (2020). Antioxidant-Based Medicinal Properties of Stingless Bee Products: Recent Progress and Future Directions. Biomolecules, 10(6), 923. https://doi.org/10.3390/biom10060923

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop